midterm Flashcards

1
Q

Function of the CV system

materials transported

  • what area of the body especially needs o2
  • hypoxia
A

a. Transport of material entering the body to sites for processing/use:
i. Nutrients – intestine  all cells
ii. Oxygen – lungs  all cells
1. Important to all cells – will otherwise become irreparably damaged & loss of consciousness without bloodflow to brain
2. Neurons – high o2 demand; can’t use anaerobic methods (low ATP yield)
a. Hypoxia – low oxygen
b. Body will deprive other cells of oxygen before the brain – must keep CFS levels high
iii. Water – intestine  all cells

b. Transport of material between cells within the body:
i. Hormones – present when secreted by endocrine cells
ii. Antibodies – always present
iii. Platelets and Clotting proteins – always present
iv. Immune cells (leukocytes) – always present
v. Stored nutrients – glucose from liver and fatty acids from adipose tissue

c. Transport of material from cells to sites of elimination:
i. Wastes (urea, creatinine, bilirubin) – moved to kidneys for excretion
1. Some are transported to liver first – processing
ii. Carbon dioxide – moved to lungs
iii. Heat – moved to skin (sweat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Heart and CV anatomy

  • cyanosis
  • resistance and pressure of pulm vs systemic
  • positive pressure and valves
A

a. Heart
i. Hydraulic pump that creates a pressure gradient.
ii. Anatomy
1. Divided by septum – central wall; splits into right and left
2. Atrium – received blood returning to heart from blood vessels
3. Ventricles – pump blood out into blood vessels
a. Right – into pulmonary
b. Left – into systemic
iii. Cyanosis – low oxygen blood imparts blueish colour to areas of the skin (around mouth and under nails)

b. Vasculature – blood vessels
i. Closed (blood always carried in vessels)
1. Arteries – away from heart
a. To pulmonary – deoxygenated (doesn’t completely lack; just less); right ventricle
b. To systemic – oxygenated; left ventricle
2. Veins – towards the heart
a. From pulmonary – oxygenated; left atrium
b. From systemic – deoxygenated; right atrium
ii. Dual circuit that allows unidirectional blood flow
1. Pulmonary circulation – low pressure, low resistance vessels that carry blood to and from lungs
2. Systemic circulation – high pressure, high resistance vessels that carry blood to the remaining organs

c. Blood
i. Transport medium consisting of plasma and cells

d. Valves in heart and veins – unidirectional flow
i. Positive pressure behind – open
ii. Positive pressure ahead – closed
1. Usually facing you (right side is on left page)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

paths of bloodflow

pulmonary vs systemic vs coronary
- hepatic & renal circulation

A

a. Pulmonary circulation: Right ventricle ➔ pulmonary arteries ➔ arterioles ➔ capillaries in lungs (where exchange takes place) ➔ venules ➔ pulmonary veins ➔ left atrium

b. Systemic circulation: Left ventricle ➔ aorta ➔ ascending arteries and abdominal aorta ➔ systemic arteries (e.g. carotid arteries, hepatic arteries, renal arteries, etc.) ➔ capillaries ➔ venules ➔ systemic veins (e.g. jugular vein, hepatic vein, renal vein, etc.) ➔ superior or inferior vena cava ➔ right atrium
i. Aorta
1. Ascending branches of aorta – arms, head, brain
2. Abdominal aorta – trunk, legs, internal organs (hepatic, digestive, renal)
ii. Hepatic circulation
1. Hepatic artery – directly from descending artery
2. Hepatic portal vein – from digestive trace  liver
a. Liver – nutrient processing and detoxifying substances absorbed in intestines before releasing into general circulation
iii. Renal circulation – portal system between kidneys
iv. Venae cavae
1. Superior vena cava – upper body
2. Inferior vena cava – lower body

c. Coronary circulation: left ventricle –> aorta –> coronary arteries –> cardiac muscle capillaries –> coronary veins –> coronary sinus –> right atrium
i. Microcirculation – arterioles, capillary beds, venules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Rate of blood flow to tissues is determined by

  • hydrostatic pressure
  • where is pressure highest and lowest
  • driving pressure
  • what is direct, what is inversely
  • equation for vascular resistance

Hydraulic pump
- when does it start beating

A

a. Pressure gradients (∆P) – differences in pressure between two locations in the cardiovascular system.
i. Pressure – force exerted on its container
1. Measured in CV in mmHg – 1 mm of mercury is equivalent in hydrostatic pressure exerted by a 1mm high column of mercury on an area of 1cm2
2. Hydrostatic pressure – exerted when fluid is not moving; equal in all directions
a. Still used in physio even through blood is flowing
3. Does not affect volume
4. P is not the same as absolute pressure – 2 tubes can have different absolute pressures but the same flow rate
ii. Pressure decreases with increasing volume  blood flows passively into heart chambers between contractions
iii. Blood flows from areas of high pressure to areas of low pressure, (down the pressure gradient)
1. highest closest to the ventricles & aorta
2. driving pressure – created by the ventricles; drives blood through blood vessels
3. decreases as you move further away from this pump
4. lowest in vena cava & atria
iv. Blood flow –> directly proportional to change in P
1. greater the pressure difference - higher the flow.
2. smaller the pressure difference - lower the flow.
3. no pressure gradient (∆P = 0) - there is no flow.

b. Flow is inversely proportional to resistance (F proportional to P/R)
i. Vascular resistance – resistance to blood flow; caused by friction (of blood cells in contact with vessel walls and with each other).
ii. Increased surface area in contact with blood = increased resistance (L and r)

c. Vascular resistance - is determined by:
i. Vessel length (L) – smaller impacts
1. longer = increased resistance
ii. Internal vessel radius (r) – large impacts
1. Vasoconstriction – decreasing radius, increases resistance
2. Vasodilation – increasing radius, decreases resistance
iii. Blood viscosity (η) – friction between molecules in a flowing fluid; small impacts
1. proportional to hematocrit – the proportion of the blood volume that is red blood cells
a. Increasing hematocrit  increases viscosity  increases resistance
b. analogy: water (low viscosity) vs honey (high viscosity) moving through a tube
iv. The equation: R = 8Lη/ πr4
1. where 8 and π are constants.
2. L (vessel length) does not change in humans
a. exception – lengthening of blood vessels that occurs in obesity
3. η (viscosity) – relatively constant.
4. Radius (r) – main determinant in R (resistance)
a. Resistance is proportional to 1/r4
b. a small change in the radius, produces a large change in resistance – increasing the radius 2x decreases resistance by 16x

f. Hydraulic pump – required in order to sustain the pressure gradients needed to create the blood flow necessary to transport material (nutrients, gases, wastes, etc.) throughout the body
i. The heart is a fascinating organ in that begins beating after only 3-6 weeks after fertilization
ii. It will beat on average 3 billion times before we die, and even when removed from the body, it can continue to beat on its own, without any need for nervous stimulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Poseuille’s law

2. Velocity of flow

A

d. Poseuille’s Law:
i. Equation that combines the effects that pressure gradients and the factors determining resistance have on blood flow:
1. IMPORTANT NOTE: Poseuille’s law as given in the text is not correct, as it only addresses resistance and does not incorporate pressure gradients.

F = (change in P)(pi r ^4)/(8Ln)

e. Velocity of Flow – the distance a fixed volume of blood travels in a given period of time (how fast)
i. NOT the same as flow rate – the volume of blood that passes a given point in the system per unit time (how much)
1. Units: mL/min or L/min
ii. Formula: v = Q/A
1. Q = Flow rate – directly related
2. A = cross-sectional area of the tube – inversely related to velocity
a. Velocity increases when cross sectional area decreases (arteries)
b. Velocity decreases when cross sectional area increases (capillaries)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Heart structure

A

a. Center of the thoracic cavity – ventral side; between lungs
i. Apex – angles downward to the left; rests on the diaphragm
1. Must contract from apex up in order to push blood through aorta and trunk at the top of the ventricles
ii. Base – faces upward; major blood vessels emerge from

b. Four chambers
i. Left and right atria – much smaller walls than ventricles
1. Right atria – receives deoxygenated blood from systemic circuit via inferior and superior vena cava
2. Left atria – receives oxygenated blood from pulmonary circuit via 2 right and 2 left pulmonary veins
ii. Left and right ventricles – the majority of the heart
1. Right ventricles – sends deoxygenated blood into pulmonary circuit via pulmonary trunk  2 right and 2 left pulmonary arteries
2. Left ventricle – send oxygenated blood into systemic circuit via aorta

c. Walls of each chamber are composed of 3 layers:
i. Endocardium – inner epithelial lining of the heart (continuous with lining of blood vessels)
ii. Myocardium – cardiac muscle cells
1. joined together by intercalated disks that contain gap junctions – allow ions to flow directly between cells (electrical coupling)
iii. Epicardium (= visceral pericardium) – epithelial lining covering the outer surface of the heart

d. Pericardial sac – surrounds and protects the heart
i. 2 layers
1. Fibrous pericardium – thick layer of connective tissue; anchors the heart in place
2. Parietal pericardium – fused to fibrous pericardium; faces cavity
ii. Pericardial cavity – between pericardial sac and epicardium/visceral pericardium
1. Contains serous fluid – reduces friction during contraction
iii. Prevents overdistension of the heart and anchors it to surrounding structures.
iv. Pericarditis – inflammation of pericardium; friction rub against the heart

e. Heart Valves – passive unidirectional valves (open in response to changes in pressure); prevent the backflow of blood from the ventricles to the atria or from the large vessels to the ventricles.
i. Atrioventricular valves – between atria and ventricles
1. tricuspid valve – between right atrium and right ventricle.
2. Bicuspid valve (mitral) – between left atrium and left ventricle (bi people are left)
3. Respond to pressure gradients
a. High pressure in the ventricles due to ventricular contraction – closes them
b. Relaxation of ventricles causes ventricular pressure to fall below that of atria – opens them
4. Chordae tendineae – attach papillary muscles of the AV valves to the ventricular side; prevents opening into atrium from ventricular pressure
ii. Semilunar valves – between ventricles and larger arteries; each has 3 leaflets
1. aortic semilunar valve – between left ventricle and left
2. pulmonary semilunar valve – between right ventricle and pulmonary trunk
3. Respond to pressure gradients
a. High pressure in the ventricles due to ventricular contraction – opens them.
b. Relaxation of ventricles causes ventricular pressure to fall below that of the aorta – closes them

f. Fibrous skeleton – connective tissue rings that:
i. Prevent collapse of valve openings.
ii. Physically and electrically separate atria from the ventricles – allows independent contraction
1. allowing atria to contract as a unit to push blood down into ventricles
2. allow ventricles to contract as a unit to push blood upwards into the major blood vessels (aorta and pulmonary trunk/arteries)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cardiac muscle

  • characteristics
  • conduction system
  • types of cardiac cells
A

does not require a stimulus from the nervous system in order to contract. (unlike skeletal)

myogenic – originating within the heart itself

The conduction system – non contractile cells that are capable of spontaneously creating and conducting the action potentials & stimulate contractile cardiac cells
o Signal spreads through gap junctions (wavelike) – allows appropriate and simultaneous contraction of atria then ventricles to form heartbeat

Types of cardiac cells
o Normal – contractile cell; myocardium
 99% of cells
 Larger than noncontractile, smaller than skeletal
 striated, mononucleated
o Modified/specialized – intrinsic conduction system; non contractile (not striated)
 1% of cells
 Auto-rhythmic cells – generate AP; pacemakers
 Conducting cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Non contractile cells

  • how long is AV node delay
A

no sarcomeres/striation; generate and conduct action potentials.

  1. Autorhythmic pacemaker cells – AP of SA and AV are influenced by NS and endocrine (allows for regulation for sleep/exercise/etc)
    a. Sinoatrial (SA) Node – In right atrium
    i. generates action potentials (APs) at a rate of 100 APs/min
  2. modified by PSNS – 75 APs/min at rest
    ii. natural pacemaker – generates the fastest AP in the heart
    iii. damage – atria may not contract
  3. AP will be produced at the rate of the AV node (50 APs/min) – may not be high enough to sustain life functions.
  4. Artificial pacemaker with battery and electrode can be surgically implanted under the skin – artificially stimulate the AV node (not SA node) cells at a rate that is within normal range
    b. Atrioventricular (AV) node – in right atrium
    i. generates action potentials at a rate of 50 APs/min
    ii. Small diameter cells with few gap junctions – slows down the conduction of AP; creates ~100 ms to ensures the atria contract and are fully empty before ventricular contraction begins
    c. Purkinje fibres – in ventricles
    i. Generates AP at 25-40 bpm
  5. Conducting cells – large diameter conducting cells (can be autorhythmic)
    a. Interatrial pathway
    i. Carries signals from SA node (right atrium)  left atrium
    ii. Causes contraction of atrial myocardium
    b. Internodal pathway
    i. Carries signals from SA node to AV node
    c. AV node – slowed conduction to allow atrial contraction
    i. Signal must enter here – fibrous skeleton blocks elsewhere
    d. Atrioventricular/AV bundle/Bundle of His
    i. Pathway of AP from atria to ventricles.
    ii. Carries quickly through ventricular septum – bundle splits into Bundle Branches that carry the signal to the apex
    e. Purkinje Fibers (”subendocardial conducting network”)
    i. Terminal branches – transmit impulses (AP) to contractile cells of ventricles & stimulates contraction upwards starting at apex
    ii. Must start at apex in order to push blood upwards into blood vessels
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Action potentials in

  1. Pacemaker cells
  2. Contractile cells
A
  1. Action Potentials In Pacemaker Cells (SA node and AV node)
    a. Pacemaker potential – unstable membrane potentials that are capable of spontaneously producing AP
    i. No RMP – cell is constantly depolarizing and hyperpolarizing
    ii. Threshold is -40mv
    iii. If (funny) channels open – Na+ enters the cell & depolarizes to threshold.
  2. Funny – allows current to flow; unusual properties (allows both K+ and Na+ through but Na+ influx exceeds K+ outflux)
  3. Slow depolarization due to movement of K+ and Na+
    b. Depolarization phase – at threshold
    i. If (funny) channels close – Na+ influx stops
    ii. Voltage gated Ca++ channels open – Ca2+ enters rapidly and depolarizes to peak
    c. Repolarization phase
    i. At peak (+20mv) – voltage gated Ca++ channels close & slow K+ channels open
  4. K+ exits the cells – hyperpolarizes
    ii. At -60mV voltage gated K+ channels close – If channels reopen & cycle begins again
  5. Action Potentials In Myocardial Contractile Cells
    Phases:
    a. Phase 4: Resting Membrane Potential
    i. Is -90mv in contractile cardiac cells
    b. Phase 0: Depolarization phase
    i. Depolarization of autorhythmic cells spreads through gap junctions to contractile cells.
    ii. Voltage gated Na+ channels open – Na+ enters cell until membrane is depolarized to +20 mV.
    c. Phase 1: Initial Repolarization Phase – slight drop
    i. Na+ channels close, fast K+ channels open, K+ leaves cell causing repolarization.
    d. Phase 2: Plateau
    i. Voltage gated Ca2+ channels open, fast K+ channels close.
    ii. Ca2+ entry & decreased permeability to K+ prolongs depolarization and slows hyperpolarization
    e. Phase 3: Repolarization phase – large drop
    i. Ca2+ close
    ii. Voltage gated slow K+ channels open, K+ exits cell and membrane potential returns to resting levels.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cardiac contraction

  1. AP delay
    - importance of refractory period
  2. excitation contraction coupling
  3. graded contractions
A
  1. Cardiac contractile cell AP – are much longer (~250 ms) than in skeletal muscle cells (1-2 ms) due to the plateau phase.
    a. Extends the Absolute refractory period
    i. It is almost as long as the contractile response – contraction + relaxation
    b. Long absolute refractory period has 2 important effects
    i. Prevents tetanus – second AP/contraction can’t be initiated before first is complete; prohibits summation of contractions
    ii. Allows for alternation of contraction and relaxation of the myocardium with enough time in between beats for the chambers to fill with blood (i.e. heartbeat).
  2. Excitation Contraction Coupling in Myocardial Cells
    a. AP arrives at the myocardial cell from contractile cell – travels across sarcolemma and infiltrates through t-tubules
    b. Voltage gated L type Ca2+ channels of t-tubules open – Ca2+ enters cell
    c. Ca++ binds to and opens ryanodine receptor (RyR) Ca++ release channel on the membrane of the sarcoplasmic reticulum (SR)
    i. Provides 90% of Ca2+ needed – other 10% comes from ECF (t-tubules)
    d. This process is Ca2+ induced Ca2+ release. – leads to a Ca2+ signal.
    e. Ca2+ ions bind to troponin – initiates contraction cycle and crossbridge formation (myosin binds to actin, powerstroke, etc).
    f. Relaxation of the cell
    i. Ca++ ATPase pumping Ca++ into the SR
    ii. Na+/ Ca++ Exchanger (NCX) – an antiport that moves Ca2+ into ECF in exchange for Na+.
  3. Na+ that enters is removed by Na+ K+ ATPase
    iii. As Ca++ levels in the cytosol decrease, Ca2+ unbinds from troponin, stopping the contraction cycle.
  4. Cardiac muscle can execute graded contractions – fibre varies in the amount of force it generates
    a. Skeletal muscle – all or nothing
    b. Cardiac muscle – proportional to the amount of crossbridges that are active (determined by amount of Ca2+ is bound to troponin)
    c. Also affected by length of sarcomere – a function of how much blood is present in the chambers of the heart (relationship between force and ventricular volume)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ECG

  • how they work
  • einthovens triangle
  • shows what

waves vs segments vs intervals
- can you tell whether its de or repolarizing in waves

A
  • Electrical activity in the heart can be measured using electrodes placed on the surface of the skin – salt solutions (NaCl) are good conductors
  • Einthoven’s triangle – at least 3 electrodes are required, placed in a triangular formation on the arms and legs
    o 6-12 electrodes are typically used in clinical practice
  • Shows the summed electrical activity generated by all of the cells in the heart during the cardiac cycle – net charge movements
    o It is NOT the same as an action potential – it is summing multiple AP taking place

ECG tracing – waves and segments that correspond to electrical activity in the heart.
- Waves – parts that go above or below traceline
o You cannot tell if a wave if depolarizing or repolarizing by it’s shape relative to the baseline
- Segments – sections of baseline between 2 waves
- Intervals – combinations of waves and segments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phases on ECG

A
  1. P wave – atrial depolarization  quickly followed by atrial contraction
  2. PR Segment – spread of AP to AV node; AV node delay allows completion of atrial contraction
    a. Atria pushes last 20% of blood into ventricles  active filling of ventricles
  3. QRS Wave (Complex) – Ventricular depolarization
    a. atrial repolarization also occurring – masked by ventricular depolarization (large wave)
    b. Spreads through AV bundles – ventricular contraction begins
  4. ST segment – All fibers in the ventricles are contracted
    a. Atria is relaxed
  5. T wave – Ventricular repolarization
    a. Ventricular contraction continues halfway through wave
  6. TP segment – atria and ventricles relaxed and passively filling
  7. (80% of blood enters ventricles through passive filling)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Analysis of ECGs

  • what info can be had
  • what is normal, high, low

ECG abnormalities

A

What is the heart rate
o Normal range – 60-100 bpm
o Higher than 100 bpm – tachycardia
o Lower than 60 bpm – bradycardia

  • Is the rhythm regular?
  • Are all waves and segments present in a recognizable form?

ECG Abnormalities – result in arrythmias

  1. Heart Block – damaged AV node; conduction through AV node is delayed; longer PR segment
    a. 1st Degree – all waves present; PR segment (AV node delay) longer than normal.
    b. 3rd Degree - complete blockage of signal from atria to ventricles; ventricles contract at AV bundle action potential rate of 30 APs/min.
    i. Results in asynchronous contraction and relaxation of atria and ventricles.
    ii. Many P waves, fewer QRS waves. P waves not followed by QRS wave.
  2. Ventricular fibrillation – heart muscle no longer depolarizing synchronously, making coordinated pumping action impossible.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cardiac cycle

  • lag
  • 1 cycle
  • 2 states

events of cycle

A
  • Mechanical events (contraction and relaxation) lag slightly behind electrical signals (repolarization and depolarization)

1 cardiac cycle:
o systole + diastole of the atria
o systole + diastole of the ventricles

Two stages:
o Diastole – period of relaxation and filling.
o Systole – period of contraction and emptying.

Events (phases) of the cardiac cycle

  1. The heart is at rest and filling – period of both atrial and ventricular diastole
    a. Pressure in ventricles is lower than in atria  AV valves are open and passive ventricular filling occurs (80% of atrial blood)
    b. Ventricular volume increases.
  2. Atrial contraction – atrial systole, end of ventricular diastole
    a. Last ~20% of atrial blood volume into the ventricles.
    i. Atrial contraction will play a larger role in ventricular filling when HR increases (ex. exercise)
    ii. A small amount of blood will enter back into the veins because there is no valve – observed as a pulse
    b. End diastolic volume (EDV) – the volume of blood at the end of ventricular diastole (~135mL)
    i. Maximum ventricular volume
  3. Isovolumetric contraction of ventricles – start of ventricular systole
    a. Early ventricular contraction – occurs prior to a change in ventricular blood volume (isovolumetric)
    b. Ventricular pressure increases – closes AV valves
    i. Turbulent blood flow of AV valves closing causes first heart sound (“lub”)
    ii. Pressure is not high enough to cause ejection
    c. Atria are in diastole and filling
  4. Ventricular ejection – ventricular systole, atrial diastole
    a. Ventricular pressure increases further – opens semilunar valves
    i. Pressure created is the driving force of movement of blood through CV system
    b. Stroke volume – volume of blood ejected from each ventricle
    i. SV = EDV – ESV
    ii. ~ ½ of ventricular blood volume enters aorta & pulmonary arteries
    c. End Systolic Volume (ESV) – volume of blood left in each ventricle at the end of ejection (~65mL)
    i. Minimum ventricular volume
  5. Isovolumetric relaxation of ventricles (start of ventricular diastole)
    a. Aortic pressure increases above ventricular – semilunar valves close
    i. Turbulent blood flow of semilunar valve closure causes second heart sound (“dup”)
    b. ventricular tension decreases, and pressure falls – still too high for AV valves to open, so no blood enters ventricles (hence iso)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cardiac output

  • detemined by
  • equation
  • should be what
A

CO- volume of blood ejected by each ventricle over time (i.e. rate at which each ventricle pumps blood)
- Indicates how much blood is flowing through the body – doesn’t indicate how it’s being distributed to tissues (regulated at tissue level)

Determined by
a. Heart rate – the rate at which the ventricles contract (~72bpm)
b. Stroke volume – the volume of blood pumped per contraction (~70mL/beat)
i. SV = EDV (~135mL) – ESV (~65mL)
• Can also be expressed as ejection fraction (SV/EDV)
ii. ESV – safety reserve; more forceful contraction can decrease ESV
c. Values are variable and will depend on conditions – can be modified by nervous and endocrine system
 Body can adjust CO to respond to body’s needs

HR (bpm) x SV (mL/beat) = CO (mL/min or L/min)
a. At rest: 72bpm x 70mL/beat = 5040mL/min = ~5.0L/min
b. Exercise: 200bpm x 125mL/beat = ~25000mL/min = ~25.0L/min
 During exercise – cardiac output can increase up to 5X.
 Cardiovascular athletic training/exercise – can further increase cardiac output up to 40 L/min by increasing difference between resting and exercise values for SV and HR
• Training increases heart muscle mass – increases SV
• Decreases resting heart rate – maximal HR remains the same

CO should be the same for each ventricle – can become imbalanced if one side of heart starts to fail; blood will accumulate on the weaker side

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Factors that affect HR (4)

  • where does neural control stem from
A

chronotropic agents
1. Chronotropic agents – will affect the autorhythmic cells

  1. Intrinsic control
    a. SA node – ~100 AP/min
    b. Modified by the ANS and endocrine
  2. Neural Control – stem from medulla oblongata
    a. Antagonistic tonic control – both SNS and PSNS are active at all times
    i. Normally dominated by PSNS
    ii. Increased SNS = decreased PSNS & vice versa
    b. Parasympathetic (PSNS) – dominant at rest (~72bpm)
    i. Mechanism:
  3. Vagus nerve neurons (PSNS) – releases acetylcholine.
  4. ACh binds to mAChR of SA node cells – initiates signal transduction (muscarinic = GPCR); results in:
    a. Increase in K+ permeability – hyperpolarizes the pacemaker potential and
    b. Decrease in Na+ and Ca2+ permeability – slows the rate at which the pacemaker potential depolarizes.
  5. Slows the time required to reach threshold – decreases the rate of AP and therefore the HR
  6. Slows the conduction through the AV node
    c. Sympathetic (SNS) Control – required to increase HR above intrinsic rate (100bpm)
    i. Mechanism:
  7. Thoracic nerve neurons (SNS) – release norepinephrine (NE).
  8. NE binds to B1 NE receptors (GPCR) of SA node cells – increases cAMP second messenger system; results in:
    a. Decrease in K+ permeability – depolarizes the pacemaker potential
    b. Increase in Na+ and Ca2+ permeability – increases rate at which the pacemaker potential depolarizes.
  9. Shortens the time required to reach threshold – increases the rate of AP and therefore the HR
  10. Also increases rate of conduction through the AV node
  11. Hormonal Control
    a. Mechanism:
    i. Epinephrine – secreted by the adrenal medulla as a result of increased SNS
  12. reinforces the effects of the SNS action on the heart (increase HR)
  13. the effect of E is the same effect as NE released by neurons (binds to B1 receptors)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Factors that affect SV (6)

A
  1. Ionotropic agents – any factor that increases the force of ventricular contractility will increase SV or the length of the myocardium
    a. Factors will affect the contractile cells of myocardium (not the autorhythmic)
  2. Neural Control
    a. Parasympathetic (PSNS) Control – none (little to no vagal innervation of contractile cells)
    b. Sympathetic (SNS) Control
    i. Mechanism:
  3. SNS neurons release norepinephrine
  4. NE binds to B1 adrenergic receptors on contractile cells, stimulating the cAMP second messenger system. Effects:
    a. Phosphorylation of L-type calcium channels – causes them to open wider; increases flow of Ca2+ into contractile cells from t-tubule after AP on sarcolemma
    b. Increased release of Ca2+ from the sarcoplasmic reticulum (SR) (increased calcium induced calcium release).
    c. More Ca2+ in the cytosol, increases the number of crossbridges between actin and myosin, and increases the speed of crossbridge cycling.
    d. Phosphorylation of phospholamban – increases activity of Ca2+ ATPase in SR membrane, increasing the speed of relaxation (able to start filling again sooner)
  5. i to iii increase ventricular contractility – at any given end diastolic volume (i.e. SNS stimulation operates independently of length tension relationships)
    c. Significance: SNS stimulation:
    i. Increases force of ventricular contraction – increases the ejection fraction which increases SV.
    ii. Increases contraction/relaxation speed – shortens systole & increases duration of diastole.
  6. SNS also increases heart rate (decreases the time for ventricular filling) – quicker relaxation compensates for shorter diastole; would otherwise not be able to maintain SV
    a. Each cardiac cycle takes
    i. ~0.8 sec at rest/72 bpm
    ii. only 0.3 sec at 200 bpm.
    iii. Increases the force of atrial contraction
    iv. Increases vasoconstriction of peripheral veins – increases venous return to heart
  7. blood enters the ventricles faster – ensuring sufficient filling and further compensation for increased HR
  8. overall effects – help to maintain/increase EDV, and help to maintain, if not increase SV
  9. Hormonal Control
    a. Mechanism: The mechanism of action of hormonal epinephrine is the same as that for norepinephrine released by the SNS (cAMP second messenger is activated, etc).
  10. Intrinsic Control (EDV affects ventricular preload. - the degree of myocardial stretch before contraction begins)
    a. Length tension relationship – the force of ventricular contraction varies in response to how much the ventricular myocardium is stretched upon filling
    i. At rest – cardiac fibers are at less than optimal length (which is 2.2 µm).
    ii. Increasing EDV (ex. increasing venous return) – cause cardiac cells to stretch and approach optimal length; allows more crossbridges to form between actin and myosin & increases the force of contraction and SV
    b. Frank Starling’s Law of the Heart – force of ejection (SV) is directly proportional to the EDV; determines the degree of stretch in the cardiac muscles.
    i. i.e. the more blood in during diastole (increased EDV), the more blood comes out during systole (increased SV) and vice versa.
  11. Venous Return – the amount of blood returning to the heart from veins; directly affects EDV and therefore SV and CO
    a. Factors determining EDV:
    i. Neural control:
  12. Increases SNS activities blood vessels – NE binds to a1 receptors & causes vasoconstriction
  13. Vasoconstriction in response to decreased mean arterial pressure (or exercise) strongly increases venous pressure and therefore venous return.
  14. Increased tension in the vein wall decreases compliance (i.e. blood will not be able to pool in veins), which also increases venous return and therefore increase EDV, SV, and cardiac output.
    ii. Skeletal muscle pump
  15. Large muscle groups compress deep veins in the legs (and arms) when they contract.
  16. Compression & valves in large veins – prevent backflow of blood; ensures that when muscles are contracting (like during exercise) more blood is moved towards the heart.
  17. So exercise and contracting muscles – pushes blood back toward the heart, increasing venous return  increases EDV, SV and CO
  18. At rest (sitting) – the skeletal muscle pump is usually not working (unless you are doing calf raises or other exercises while seated)
    iii. Respiratory pump
  19. Venous return depends on the pressure gradient (∆P) between peripheral veins and the right atrium.
  20. Right atrial & thoracic vena cava pressure – is affected by changes in thoracic cavity pressure.
    a. During inspiration – contraction of the diaphragm decreases pressure in the thoracic cavity and increases pressure in the abdominal cavity; results in:
    i. Compression of abdominal veins  increasing their pressure
    ii. Distension of thoracic cavity veins and the right atrium  decreasing their pressure
    b. Increased abdominal vein pressure and decreased pressure of thoracic veins/right atrium causes larger P and more blood to flow into thoracic veins and into the right atrium (i.e. increases venous return)
  21. The larger the inhalation  the greater the ∆P  the greater the venous return.
  22. Afterload
    a. SV depends on the arterial pressure against which it is pushing  greater arterial pressure = smaller P
    i. Semilunar valves only open once ventricular pressure becomes greater than aortic pressure.
    ii. Increased MAP = increased aortic pressure = more force required to eject the same volume of blood from ventricles against the pressure in arteries
    b. Increased afterload only becomes a problem in diseased states:
    i. Chronic hypertension (>140/90 mmHg)
    ii. Stenosis of the semilunar valves
    iii. Coarctation of the aorta
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Blood vessel structure

  • what is constant and what can change
  • structure
A

Blood flow to specific organs – can be modulated by changing the pressure gradients, radius, length, viscosity
o Length and viscosity – relatively constant
o Radius and P – able to modulate

Blood vessel structure – not all blood vessels have all components

  1. Tunica intima – innermost layer; single layer of endothelial cells.
    a. Continuous with endothelial lining (endocardium) of heart.
    b. Secrete paracrines – regulate blood flow, blood pressure, vessel growth, absorption of materials
  2. Elastica interna – made of elastic protein fibers (elastin) that are capable of stretch and recoil.
  3. Tunica media – vascular smooth muscle; contraction and relaxation change radius; often partially contracted on most BV (muscle tone)
    a. Contraction = vasoconstriction
    i. Depends on entry of Ca2+ from ECF
    b. Relaxation = vasodilation.
  4. Elastica externa – layer of elastin
  5. Tunica externa – outer layer of connective tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Types of blood vessels

  • what is in walls
  • functions
A
  1. Arteries - thick walls with lots of elastic tissue.
    a. Large elastic arteries (ex. aorta) - large diameters (radii) with little resistance to blood flow (F = ∆P/R)
    b. Artery pressure reservoir helps to maintain:
    i. maintain driving pressure of blood flow during ventricular relaxation (diastole)
  2. stretch in order to accommodate blood during ventricular systole
  3. recoil during diastole maintains pressure
    ii. constant flow of blood toward capillaries – maintains P
    c. Elasticity – allows them to expand to accommodate ventricular ejection
    d. Thickness – maintains pressure on blood that allows passive elastic recoil , pushing excess blood downstream.
    e. Low compliance (low capacitance) vessels – low ability of the vessel to stretch and increase volume with increasing transmural pressure (∆ volume / ∆ transmural pressure = low)
    i. Stiff fibrous tissue
  4. Arterioles:
    a. Thick walls – little elastic tissue & lots of smooth muscle
    i. Innervated by sympathetic nerves (except penis and clitoris which have innervation from PSNS).
  5. The amount of smooth muscle and innervation progressively decrease in the arterioles as they get closer to the capillaries.
  6. Arteries  arterioles will have less elasticity and more muscle
    ii. Metarterioles – do not have a continuous smooth muscle layer
    b. Functions:
    i. Determine the relative blood flow to individual organs/tissues through vasoconstriction and vasodilation.
    ii. Help maintain mean arterial pressure (MAP).
    iii. Eliminate the pulse pressure prior to it reaching the capillaries (eliminates pulsatile changes in flow/pressure in capillaries).
  7. Capillaries:
    a. Function in exchange between vessels and ISF – highly permeable to small lipid soluble substances (o2, co2, FA, steroids, anesthetics, etc)
    i. Smallest, thinnest, most numerous blood vessels in body.
  8. 5-10 µm in diameter – huge surface area (~6000 m2) for exchange
  9. Contain 5% of circulating blood at rest.
    ii. A single layer of endothelial cells surrounded by thin glycoprotein/collagen matrix (basement membrane)
    b. Two classes – allow differing levels of exchange
    i. Continuous capillaries – cells connected by leaky junctions (small intercellular spaces)
    ii. Fenestrated capillaries – large intercellular spaces (junctions) between cells and large channels (pores) passing through cells.
  10. Found in kidney (glomerulus), intestines, liver, bone marrow (in liver and bone marrow = discontinuous capillaries).
    c. Closely associated with pericytes – contractile cells that surround capillaries; determine “leakiness” by how many are present
    i. Secrete factors – capillary growth, can differentiate to become new endothelium/smooth muscle cells
  11. Veins
    a. Venules converge & form – larger venules have some smooth muscle
    i. Smaller – more similar to capillaries
    b. Thin-walled, valved, high compliance vessels (expand easily with increasing pressure)
    i. Contain less smooth muscle and elastin
    ii. More collagen (connective tissue) than arteries
    c. Enlarge as they travel towards heart – maintains P for blood flow
    d. Functions:
    i. Low resistance/high compliance vessels for blood flow
  12. Mean driving pressure (P) for blood flow from veins to right atrium is only 10-15 mmHg.
  13. Combined with the large cross-sectional area – low velocity of flow & pooling of blood in veins forming volume reservoir
    ii. Volume reservoir – hold a much greater volume of blood than arteries, even though pressure is much lower
  14. Reservoir can rapidly be drawn on when required
    a. Constriction of veins prevents pooling of blood & increases venous return
    b. Dilation of veins allows blood to pool inside of them and decreases return
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Distribution of blood throughout the body

main site of resistance

  • modulating resistance
  • vascular tone modulation
A

• Different organs require different amounts of blood flow both at rest and as activity changes – body needs a way to allow for changes in blood flow to different organs
• CO from the left ventricle is ~5.0 L/min (based on average HR and SV)
o Most blood from the left ventricle at rest goes to the liver  flow rate to the liver is 27% x 5.0L/min = 1.35L/min
o The least amount goes to the heart (4%) and skin (5%) at rest – these increase with increased activity
o 20% goes to skeletal muscle at rest – can increase to as much as 85% during exercise
o Total blood flow through all the arterioles of the body always equals the cardiac output
• Pulmonary circuit – blood flow to the lungs occurs at 5.0L/min coming from the right ventricle  the entire volume of the body’s blood passes through the lungs each minute

  1. F = P/R
  2. Arterioles – main site of variable resistance (>60% of total resistance); due to smooth muscle in walls
  3. Controlled by
    a. Changing arteriolar resistance (not “regulation”) – blood will be diverted to arterioles with less resistance
    i. Arteriole radius can be adjusted independently of one another – allows for specific changes in different organs
  4. Smooth muscle can contract (vasoconstriction) or relax (vasodilation) to produce changes in R and F
    ii. Rate of blood flow to each organ – depends on the degree of contraction and relaxation in the arterioles that supply blood
    b. Contraction/relaxation of precapillary sphincters – bands of smooth muscle at junction between arterioles and capillaries
    i. Open – blood flows into capillary bed
    ii. Closed – blood flows directly from arteriole to venule through metarterioles (connecting vessels); does not enter capillaries
  5. Vascular tone – state of partial contraction independent of neural signaling and chemical effects (hormones, vasoactive mediators)
    a. Baseline constriction of arterioles – can be modified by external signals to increase or decrease concentration of cytosolic Ca2+ in smooth muscle
    i. Increasing Ca2+  increases tension
    ii. Decreasing Ca2+  decreases tension
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Regulation of blood flow (not pressure)

  1. Intrinsic mechanisms
  2. extrinsic mechanisms
A

local is dominant

  1. Intrinsic (local) autoregulation mechanisms:

a. Heart & brain – tissue metabolism is the primary factor that determines arteriolar resistance
i. Brain tissue – high sensitivity to oxygen and glucose levels; relatively constant under normal circumstances
1. Increases in systemic BP – may trigger myogenic responses; causes vasoconstriction to regulate
2. Metabolism is the primary factor
a. Buildup of co2 – vasodilation (can be observed at PET and fMRI scans)
ii. Coronary blood flow – myocardium takes up 75% of oxygen
1. Whereas only 25% of o2 sent to systemic tissues is taken up – 75% is still present
2. Lack of oxygen (myocardial hypoxia) causes the release of adenosine – causes vasodilation and increased blood flow

b. Myogenic control – ability of vascular smooth muscle within vital organs to regulate its tone in response to changes in blood pressure
i. Increasing blood pressure stretches the smooth muscle in the arteriole
1. Stretching causes opening of mechanically gated Ca2+ in smooth muscle membrane – allows Ca2+ to enter & form crossbridges to increase tension
ii. Example 1: when you stand, the arterial pressure and flow in the feet increase  increase in pressure in the feet causes the arterioles to stretch & allows more Ca2+ into the cells  the smooth muscle contracts, resulting in vasoconstriction (increased tone)  reduces flow in the feet.
iii. Example 2: When you stand up (from a supine position), the cerebral arterial pressure decreases  reduces the amount of stretch in the arterioles  smooth muscle relaxes (less stretch, less Ca2+)  vasodilation (decreased tone)  increases blood flow to the brain

c. Local Metabolic Control – many tissues can control blood supply be releasing paracrine molecules in response to changes in metabolic activity
i. Paracrine release into ECF  endothelium of the arterioles release vasoactive mediators – directly effects arteriole smooth muscle and causes either contraction or relaxation (e.g. nitric oxide, (NO))
ii. Active hyperemia – increase in blood flow in tissue in response to increase in tissue activity (metabolism)
1. O2 decrease and co2 increases with increasing metabolism – causes relaxation of smooth muscle and increased blood flow to organ/tissue
iii. Reactive hyperemia – increase in tissue blood flow following a period of low perfusion (waste removal is not occurring at optimal level)
1. Vasodilation – caused by autoregulatory myogenic and metabolic factors
a. Myogenic – reduced flow/pressure decreases stretch and causes relaxation (vasodilation)
b. Metabolic – local hypoxia (lack of o2) and accumulation of metabolic byproducts causes vasodilation through synthesis of NO
2. Triggering of myogenic and metabolic – causes rapid restoration of local cellular conditions
iv. Exercise
1. Rapid contraction in skeletal (and cardiac) muscle leads to:
a. Local reductions in O2 levels (hypoxia)
b. Local increases in CO2, H+, K+, and adenosine levels (metabolic waste products)
2. Causes vascular endothelial cells to secrete nitric oxide at these sites – reduces Ca2+ entry into adjacent smooth muscle cells causing local vasodilation of
a. Arterioles – increases blood flow to active tissues
b. Precapillary sphincters – increases number of open capillaries in active tissues
3. Result in increased O2 delivery and increased waste removal by blood.

d. Non-metabolic chemical mediators
i. Endothelin-1 – released from arteriolar cells in response to an increase in pressure.
1. Causes vasoconstriction – opening non-stretch sensitive Ca2+ channels and enhancing Ca2+ release by the sarcoplasmic reticulum in smooth muscle cells.
ii. Histamine – released by mast cells of the immune system.
1. Causes vasodilation and plays a role in inflammation – localized release occurs during allergic reactions (quick onset) or in response to injury/infection (2-8hr onset); causes swelling and redness
iii. Serotonin – In the blood, serotonin is released from platelets in response to a wound.
1. Causes vasoconstriction – vascular spasm is part of hemostasis; acts to reduce blood flow to the site of the wound (prevents blood loss)

  1. Systemic (extrinsic) mechanisms – signaling from NS or endocrine
    a. Can create body wide changes in blood flow and blood pressure (systemic).
    i. Extrinsic control of arteriolar radius across multiple organ systems alters Total Peripheral Resistance (TPR) – an important regulator of Mean Arterial Pressure (MAP).
  2. F = P/R  P = F x R
    a. Sub: CO for F, MAP for P, TPR for R
    b. MAP = CO × TPR
    ii. Increasing or decreasing TPR by systemic vasoconstriction or vasodilation will change:
  3. The blood flow in those systems
  4. Will also have a measurable effect on blood pressure – unlike myogenic/metabolic (local)

b. Neural Control – SNS only (except for penis and clitoris)
i. Sympathetic neurons mainly release NE – binds to arteriolar smooth muscle a1 adrenergic receptors  vasoconstriction
1. brain arterioles lack a1 adrenergic receptors (as do terminal arterioles) – their radius/diameter is entirely controlled by local mechanisms (i.e myogenic/metabolic control).
ii. Sympathetic nerves constantly discharge at an intermediate rate (in addition to basal tone) – firing rate is controlled by the cardiovascular center in the medulla oblongata of the brain.
1. increased firing – generalized* vasoconstriction (↑ TPR) & venoconstriction (constriction of veins)
2. decreased firing – generalized vasodilation (↓ TPR)

c. Hormonal Control
i. Epinephrine – released from adrenal medulla in response to SNS stimulation
1. In skin and most abdominal viscera – binds to smooth muscle a1 receptors; reinforces SNS vasoconstriction (promiscuous receptors)
2. In heart, liver and skeletal muscle – binds with greater affinity to non-innervated B2 receptors that bind epinephrine with higher affinity
a. Vasodilation in these tissues – increased local metabolic control mechanisms (ex. during exercise)
3. Think about which ones need to be active during exercise (fight or flight) – will require vasodilation via B2 receptors (as well as local control mechanisms)
a. If the organs mainly function for resting and digesting – the generalized response of vasoconstriction will apply
ii. Other hormones – closely linked to control of blood volume via affects on kidney arterioles
1. Angiotensin II – activated due to decreased renal perfusion pressure (ex. decreased MAP)  causes renin secretion by kidneys  activates angiotensin II system  increase in blood volume
a. Causes arteriolar vasoconstriction (increases TPR)
2. Vasopressin (ADH) – released from posterior pituitary in response to signaling from atrial receptors  stimulated by decrease in blood volume & MAP
a. Causes vasoconstriction (increases TPR)
3. Atrial Natriuretic Peptide (ANP) – synthesized and released by specialized atrial cells in response to excess stretch in the heart (ex. increased venous return due to increased blood volume/pressure)
a. Causes relaxation of vascular smooth muscle and vasodilation (decreases TPR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Blood reg during exercise

blood reg during hemorrhage

A

Ex. blood regulation during exercise – combination of metabolic (local), neural, and hormonal
1. Local metabolic factors
a. Inactive muscles – dominated by local factors
- High local o2, low co2 & H+  vasoconstriction
b. Active muscles
- High co2 and H+, low o2  vasodilation
2. Increased SNS
o Cause increased HR, SV, CO
o NE – bind alpha receptors in non essential organs  constriction
o E – bind beta receptors in heart, liver skeletal muscle  vasodilation

Ex. blood flow during severe hemorrhage – causes MAP to decrease
1. Local Effect (e.g. at brain, or heart)
a. Decreased arteriolar stretch – myogenic
b. Decreased [oxygen] and increased [metabolic waste] at tissues – metabolic paracrines
- Result – dilation of these arterioles; increased blood flow to brain/heart
• This causes MAP to decrease further – must combine with SNS response
2. Sympathetic response
a. Increased sympathetic stimulation
- NE – vasoconstriction of smooth in non-essential organs
- E – vasodilation of skeletal muscle arterioles; this is opposed by (dominant) local metabolic effects
b. Increased plasma [vasopressin] and [angiotensin II] – prevents water loss at kidneys (affects volume)
- Result – attempt to increase MAP towards pre-hemorrhage values
• increased smooth muscle tone of most arterioles (except brain, heart) – attempt to preserve if not increase blood volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Blood pressure

  • types of pressure
  • 4 important pressures
A

• Hydrostatic pressure – a result of blood pushing against walls of blood vessels; pressure falls over distance as blood moves through CV system
o Highest pressure in arteries closest to pump (ventricles)
o Lowest pressure in veins (in the circulatory route these are furthest from ventricular pump)
o Results when flow (F) is opposed by resistance (R).
• All body pressure are given relative to atmospheric pressure and are measured in mmHg (millimeters of mercury).
o Ex. 100 mmHg = 100 mmHg above atmospheric pressure (at sea level = 760 mmHg)
• Ventricular pressure – difficult to measure; assume arterial BP is indicative of ventricular

  1. Systolic Pressure (SP) – max pressure in aorta (~120mmHg)
    a. Reached ~ half way through ventricular ejection (i.e. during ventricular systole/contraction).
  2. Diastolic Pressure (DP) – min pressure in aorta (~80mmHg)
    a. Reached at end of isovolumetric contraction of ventricles
    i. technically during ventricular systole – just after diastole ends and before ejection begins
    b. high diastolic pressure represents ability of aorta to capture and store energy during diastole
  3. Pulse Pressure (PP) – strength of pressure wave produced by ventricular contraction
    a. PP = SP - DP = ~40mmHg
    b. Decreases over distance due to friction
    c. Pressure wave travels 10x faster than blood itself – pulse in arm is occurring slightly after ventricular contraction
    i. Pulse is not felt in veins – pressure wave no longer exists; blood moves continuously
  4. Mean Arterial Pressure (MAP) – average aortic pressure over entire cardiac cycle (~93mmHg); instead of pulsating pressure
    a. Driving force pushing blood through the systemic circuit
    b. Homeostatically regulated by body to ensure adequate perfusion of organs.
    c. Calculated clinically as: MAP = DP + 1/3(SP – DP)
    i. Heart spends more time in diastole, so diastolic pressure has a larger contribution to MAP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sphygmomanoetry

A
  1. Method of measuring systolic and diastolic pressure clinically – uses a blood pressure cuff attached a pressure gauge (sphygmomanometer) and a stethoscope.
  2. Inflate cuff to occlude brachial artery (~140mmHg on the gauge) – make pressure higher than systolic pressure driving arterial blood; causes blood flow to stop; blood flow will return when pressure no longer exceeds SP
  3. Slowly release the pressure and listen for Korotkoff sounds – soft tapping sounds heard in the in vessel as blood begins to spurt through in turbulent blood flow
    a. Pressure when you hear the first sound is the systolic pressure – highest pressure in the artery
    b. Pressure when you hear the last sound is the diastolic pressure – lowest pressure in the artery after flow has returned to normal laminar flow
    c. Sounds will stop when cuff no longer compresses artery – flow will become smooth (not turbulent)
  4. Average should be 120/80 mmHg – there is a high degree of variability.
    a. Hypertension – systolic over 140 at rest and diastolic over 90
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Regulation of blood pressure (not flow)

  • brain centers
  • controlling MAP
A

• The body homeostatically regulates blood pressure by regulating mean arterial pressure (MAP)
• Blood pressure is regulated by higher brain centers as well
o Hypothalamus – mediates vascular responses for body and fight or flight responses
o Cerebral cortex – learned and emotional responses (ex. blushing, fainting in response to blood or needles)
• Respiratory and CV system work in tandem – increased CV activity usually results in increased respiration

MAP = CO x TPR (where CO = HR x SV).
MAP can be regulated by controlling (all will affect accumulation of blood in blood vessels):
1. Cardiac output
a. By increasing or decreasing heart rate
b. By increasing or decreasing the force of contraction – alter stroke volume.
c. By increasing or decreasing venous return.
2. TPR (Total Peripheral Resistance)
a. By increasing or decreasing vasoconstriction/vasodilation (arteriolar radius) – this is what is believed to cause hypertension most of the time
3. Blood Volume
a. Can influence MAP indirectly – Increasing/decreasing blood volume  increases/decreases venous return  increases/decreases stroke volume.
i. Kidney – can decrease or conserve water volume; cannot increase
ii. Drinking or IV – required to increase volume
iii. CV compensation – constriction/dilation through SNS; has limitations
b. Also increases MAP directly – increases the hydrostatic pressure of the blood (pressing harder against the walls of the vessels)
4. MAP will also depend on distribution of blood in arteries and veins
a. Arteries – low volume; only contain ~11%
b. Veins – high volume; contain ~60%; can act as a reservoir where venous constriction causes increase in venous return & redistribution of blood to the arterial side (SNS can cause)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Regulating MAP

  1. baroreceptor reflex
  2. blood volume control
A
  1. Baroreceptor reflex control – autonomic reflex; single most important mechanism for short term regulation of MAP (causes changes in TPR and CO); extremely fast response; always functioning
    a. Process
    i. Stimulus: changes in blood pressure (MAP) and pulse pressure
    ii. Receptors: Mechanical stretch receptors (baroreceptors) in aortic arch (monitors BP flowing to body) and carotid sinuses (measures BP flowing to brain)
  2. Tonically active – frequency of firing AP in baroreceptor cells is directly proportional MAP within physiological limits
  3. Exhibit adaptation – firing will initially increase/decrease; prolonged exposure to higher/lower MAP causes them to adapt firing to normal levels (hence short term)
    iii. Sensory nerves (input signal) project from the baroreceptors to the cardiovascular control center in the medulla (CVCC, integration center).
  4. Medullary CVCC – controls output by sending signals through vagus nerve (PSNS) and sympathetic nerves (SNS) to heart and blood vessels (effectors); antagonistic control
  5. Effector response that is opposite to initial stimulus – neg feedback
    b. At any given MAP, if pulse pressure increases, firing rate also increases
    c. Decreased MAP
    i. Ex. hemorrhage – causes a decrease in MAP and blood volume
    ii. Baroreceptor – only works to bring back towards normal MAP
  6. Decreased MAP  decreased arterial wall stretch  decreased baroreceptor firing  CV control increases SNS (NE, E) and decreases PSNS
    a. SNS (NE, E) – increases vascular tone, increases ventricular contraction, increases SA node firing
    b. PSNS (Ach) – decreases effect on SA node
  7. Results in – increased vascular constriction & increased TPR, increased EDV, increased SV, increased HR  increased MAP
    iii. to restore MAP – lost fluid must be replaced by shift in fluid balance or blood transfusion
  8. decreased capillary hydrostatic pressure  decreased capillary filtration
  9. increased AVP and angiotensin II  increased blood volume

d. Increased MAP
i. increased MAP  increased firing of baroreceptors in carotid artery and aorta  activation of sensory neurons  CV control
1. increased PSNS (Ach) – slowing of SA node
2. decreased SNS (NE, E) – arteriolar smooth muscle, ventricular myocardium, SA node
ii. result in – decreased heart rate, decreased force of contraction, vasodilation & decreased TPR  decreased MAP

e. Changes in BP can change – CO, TPR, or both (only one may be effective at a specific time)
i. Can be activated as a result of local regulation
ii. ex. increased BP causes vasoconstriction (local regulation) – constriction causes increase in MAP – activates baroreceptor
1. vasoconstriction has already been activated – CV center will likely decrease CO in order to decrease MAP
f. Orthostatic hypotension triggers baroreceptor reflex – standing causes pooling of blood at feed & decreases venous return
i. Venous return falls from 5L/min to 3L/min – causes decrease in MAP
ii. Baroreceptor response – causes increased CO and TPR & increase MAP
iii. Skeletal muscle pump – increased venous return when abdominals and leg muscles contract to maintain upright position

  1. Blood volume control – long term regulation of MAP
    a. Indirect effect of blood volume on MAP
    i. Changes in blood volume increase/decrease MAP  influences venous pressure, venous return, EDV and SV  all affect cardiac output
    ii. MAP = CO x TPR  change in CO due to a change in volume will change MAP
    b. Direct effect of blood volume on MAP
    i. Increased blood volume increases the hydrostatic pressure on the walls of the arteries.
    c. Blood volume is regulated by hormones secreted by the brain, kidneys and heart – hormones influence fluid intake and urine output.
    i. Vasopressin (ADH) – from posterior pituitary; increases blood volume
  2. Increases H2O reabsorption by the kidneys (diuretics increase the volume of urine produced and decrease blood volume; ADH does the opposite)
  3. Also causes vasoconstriction
    ii. Renin – from kidney; increases blood volume
  4. Triggers the conversion of plasma angiotensinogen into angiotensin II
  5. Stimulates ADH release – increases H2O reabsorption by the kidneys
    iii. Atrial Natriuretic Peptide (ANP) – from heart; decreases blood volume
  6. Increases Na+ and H2O excretion by the kidneys
  7. Inhibits vasopressin secretion
  8. Inhibits renin secretion (and production of angiotensin II).
  9. Result: all together these responses increase urine output and reduce thirst
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Hypo vs hypertension

  • primary & secondary
A
  1. Failures of pressure homeostasis – slow changes in MAP result in “resetting” of baroreceptors (adaptation) and CV responses
    a. Opposes minute to minute changes but are only activated at the adjusted higher or lower pressure level – response to deviations from new set point
  2. Hypotension – low MAP; flow out exceeds flow in & volume decreases
    a. Perfusion is not fast enough to clear wastes and bring in nutrients and oxygen
    b. May not be able to overcome gravity and o2 supply to brain is impaired (causes dizziness)
  3. Hypertension – high MAP; typically due to chronic increase in TPR
    a. Flow in exceeds flow out & blood volume increases
    i. Perfusion is too fast to allow for adequate exchange between the blood and tissues
    ii. Walls of BV may cause weakened areas to rupture and bleed into tissues
  4. cerebral hemorrhage – rupture occurs in brain; can cause stroke
  5. can be fatal if it occurs in a major artery
    b. Primary hypertension
    i. Causes – obesity, stress, cholesterol, smoking, genetics, Na+ retention, and immune system responses
  6. Initially – leads to ventricular hypertrophy (increase in cell size)
  7. Eventually – myocardial contractile function diminishes over time & leads to congestive heart failure and edema
  8. Increases risk of atherosclerosis, heart attack, kidney damage, and stroke
    ii. Treatments
  9. Exercise, ↓ Na+ intake, and weight loss – lower resting MAP
  10. Ca2+ channel blockers – promote vasodilation of vascular smooth muscle; decreases heart contractility and the rate of SA node depolarization
  11. Diuretics (opposite function of ADH) – increase urinary excretion of Na+ and H2O; decreases CO with little effect on TPR
  12. b-adrenergic receptor blockers – target b1 receptors; decreases NE and E stimulation of CO
  13. Angiotensin-converting enzyme (ACE) inhibitors – blocks production of angiotensin II; decreases TPR
    c. Secondary Hypertension
    i. increase in MAP arising from other conditions (e.g. pregnancy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Capillary movement

  • 2 modes of transport
  • capillary density
  • structure
  • 2 functions
A
  1. 2 modes of transport – depends on lipid solubility
    a. Protein channels (intracellular channels) in endothelial cell membranes – transcellular
    b. Intercellular pores between adjacent cells – paracellular
  2. Capillary density is directly proportional to metabolic activity of tissue’s cells
    a. Subcutaneous and cartilage – lowest concentration of capillaries
    b. Muscles and glands – highest
  3. Structure – thinnest walls; only simple squamous endothelial layer & basal lamina
    a. Diameter is barely size of RBC; RBC must go singe file – allows maximum transfer of o2
  4. 2 functions
    a. Rapid movement between capillaries and tissues – down partial pressure, electrochemical, concentration gradients
    i. Allows exchange sites for H2O, Na+, K+, glucose, amino acids, gases
  5. Diffusion rate – determined by concentration between plasma and ISF
  6. CO2 and O2 diffuse freely – will establish equilibrium by venous end
    ii. Mostly impermeable to macromolecules
  7. Plasma proteins (e.g. albumin) are too large – they remain in capillary
  8. Certain proteins can use transcytosis – selective; endocytosis into endothelial cell from plasma/ISF, exocytosis from cell on the other side
    iii. Velocity of flow through capillaries is very slow – due to total cross sectional & summed diameters (usually smaller = faster); there are a lot of them
  9. Allows for max exchange of gases between tissues & RBC
    b. Maintain fluid balance between plasma and interstitial fluid.
    i. Distribution of ECF between plasma (25%) and ISF (75%) – state of dynamic equilibrium due to filtration and absorption of protein free fluid by capillaries
    ii. Due to bulk flow – driven through channels & fenestrations by hydrostatic and colloid osmotic pressure gradients (Starling forces) that augment diffusion process
  10. Absorption – into capillary
    a. ISF hydrostatic pressure
    b. Plasma colloid osmotic pressure
  11. Secretion – out of capillary
    a. Capillary hydrostatic pressure
    b. Colloid osmotic pressure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Starling forces

  • 4 forces
  • 3 fluid movements
A
  1. PC = capillary hydrostatic pressure (HP) Note in text, PC is given as PH
    a. HP within capillary – favours filtration
    b. declines as blood moves from arteriole (~37 mm Hg) to venule side (~17 mm Hg) of capillary – due to friction
    i. there are exceptions to this – in kidneys (only filter) and intestines (only absorb)
  2. PI = interstitial fluid hydrostatic pressure
    a. HP outside capillary – favours absorption
    b. ~1 mm Hg
  3. πC = plasma colloid-osmotic pressure (colloid refers specifically to osmotic pressure created by proteins)
    a. osmotic pressure within capillary due to nonpenetrating solutes (osmotically active) – favours absorption
    b. ~25 mm Hg
  4. πI = colloid-osmotic pressure of interstitial fluid
    a. osmotic pressure due to nonpenetrating solutes within the ISF – favours plasma filtration (should be none; proteins are functionally non penetrating)
    b. ~0 mm Hg

Net fluid movement

  1. Net filtration pressure (hydrostatic pressure)
    a. Net P = PC – PI
    b. Movement due to HP – favours filtration along the entire length of capillary
    i. 37 – 1 = 36 mmHg
    ii. 17 – 1 = 16 mmHg
  2. Net colloid osmotic pressure
    a. Net π = πC – πI
    b. Movement due to osmotic pressures – favours absorption along the entire capillary
    i. 25 – 0 = 25 mmHg
  3. Net fluid movement
    a. Net fluid = Net P – Net π
    i. Arteriole end: 36 – 25 = +11 mmHg (filtration)
    ii. Venule end: 16 – 25 mmHg = -9 mmHg (absorption)
    b. Overall filtration is greater than absorption – creates excess
30
Q

Lymphatic system

  • function in capillary exchange
  • edema - 3 causes
A

~3L/day of excess filtrate is taken up by blind ended lymphatic capillaries
- Lymph passes through lymphatic vessels and lymph nodes – returns to the blood stream via lymphatic ducts & empty into veins near the jugular veins

Edema – failure of this lymphatic system or disease states affecting one or more of the Starling forces produce
o Causes an accumulation of ISF fluid in tissues due to:
1. Obstruction of lymph vessels
• Elephantiasis – mosquito-borne filaria worms block lymphatic flow
• Removal of lymph nodes – creates scarring and blockage of lymph vessels
2. Increased Net Filtration Pressure (Net P)
• Lymphatic system cannot keep up
• Heart failure promotes venous pooling – backing up blood into the capillaries; increases PC
3. Decreased Net colloid osmotic pressure (Net π)
• Decrease in πc causes
o liver disease – decreased plasma protein production
o kidney disease – increased protein excretion = proteinuria
o severe malnutrition – decreased protein intake
• increase in πI
o Histamine dilates arterioles (↑’s PC) and ↑’s intercellular pore size  increases capillary permeability for proteins

31
Q

Blood

volume men vs women

A

Blood – connective tissue specialized for transport and exchange of solute and fluids
- Volume
o Men - ~5-5.5L (70kg man)
o Women - ~4L (58kg)

32
Q

Plasma elements

A

~3L
1/4 ECF

a. Water (~90% weight)
b. Dissolved solutes
i. Proteins – determines plasma colloid osmotic pressure (πC ) and can act as a buffer to help maintain blood pH.
1. ~7% of weight
2. Without proteins, plasma is otherwise identical in composition to ISF
a. Osmotic pressure created offsets the filtration favoured by hydrostatic pressure
3. Including: (90% is albumin, globulins, fibrinogen, transferrin)
a. Albumins – 60% of all proteins
i. Primarily responsible for πC (colloid osmotic pressure)
ii. General carrier
b. Globulins – clotting factors, enzymes, antibodies, carriers
i. α, β globulins – transport lipids (cholesterol), some metal ions and hormones
ii. γ (gamma) globulins are immunoglobulins/antibodies – defensive
c. Fibrinogen – clotting protein (form fibrin threads)
d. Transferrin – transports iron that is not part of hemoglobin
e. Peptide/Protein Hormones
4. Liver makes most of the proteins and secretes them into the blood
a. Some immunoglobins and antibodies are synthesized and secreted by specialized blood cells
ii. Electrolytes (e.g. Na+, Cl-, H+, K+, Ca2+, HCO3-)
1. Functions: membrane excitability; buffers (HCO
iii. Nutrients (e.g. glucose, amino acids, lipids, vitamins)
iv. Gasses (e.g. O2, CO2, N2)
v. Metabolic waste products (e.g. urea, nitrogenous waste, creatinine)
vi. Trace elements and vitamins

33
Q

Formed elements

  • types of cells (3 main groups & subgroups)
  • structure of cells
  • life span
  • broken down & recycled
A

~2L

  1. Erythrocytes (Red Blood Cells or RBCs)
    a. Most numerous blood cell. Makes up >99% of blood cells.
    i. ~ 5 billion RBC’s per mL of blood.

b. Results in flattened, biconcave disk-shaped cells – lack nucleus and organelles
i. specialized for gas transport – o2 to tissues; co2 to lungs
1. do not metabolize – no mitochondria
a. glycolysis is the primary source of ATP
2. unable to make new enzymes and proteins without nucleus – unable to renew membrane components; older cells are more likely to rupture
ii. Shape is due to cytoskeleton components linked to transmembrane proteins
1. Flexible – able to squeeze through capillaries
2. Can modify shape due to osmotic changes in the blood (hypertonic = shrivel; hypotonic = swell without bursting due to shape)
iii. Shape can change due to disease
1. Sickle cell anemia – crescent shaped
2. Spherocytosis – cells round spheres instead of flattened disk
3. Changes in size (mean corpuscular volume (MCV)) – can increase in decrease with different diseases
4. Hypochromic – pale

c. Short-lived (~120 days) – rapidly produced in bone marrow
i. May rupture as they try to squeeze through capillaries; may be phagocytized by macrophages

d. Contain Hemoglobin (Hb) – oxygen transport
i. Adult Hb (HbA) structure – most commonly (there is some variation)
1. Two a-globin
2. Two B-globin protein chains
3. Each globin are bound to an iron containing heme group.
ii. Globin = protein chains; binds and transports CO2
iii. Heme = Red pigment molecule  porphyrin ring surrounding an iron (Fe2+) atom that reversibly binds to O2.
1. 70% of iron in body is found here
2. There are 4 hemes per Hb molecule – each Hb transports 4 O2; 4 Heme groups are identical
3. Gives blood its red colour which can be seen through skin as a pink colour especially in areas of thin skin (ex. the lips)
iv. Iron metabolism for Hb synthesis
1. Iron from diet actively transported into blood - process
a. transferrin binds Fe2+ after absorption in sm. Intestine and transports it to the blood
b. taken up by bone marrow and used for heme  Hb  RBC
2. Excess iron is stored in liver – ferritin proteins store until required
a. Excess iron is toxic

e. RBCs live 120 days and are then broken down in spleen – many components are recycled
i. Heme:
1. iron removed – stored in liver (as ferritin), muscle, & spleen to be recycled for future use.
2. Porphyrin ring  converted to bilirubin – coloured pigment; excreted in bile & feces; also filtered from blood into urine (metabolites of bilirubin give feces and urine their colour).
a. Jaundice = excess bilirubin in blood
DOES NOT CAUSE REDUCED HEMATOCRIT
i. Causes
1. excess RBC breakdown
2. liver dysfunction
a. Common in neonatal infants because their livers are not yet fully functional – phototherapy oxidizes bilirubin and allows for excretion
3. blockage of bile excretion
ii. Symptoms – yellowing of skin and sclera of eye.
ii. Globin: converted to amino acids and recycled.

  1. Leukocytes (White Blood Cells or WBCs) – mobile cells that play a key role in the body’s immune system response (protection)
    a. Primarily act outside bloodstream
    b. The only fully functional cells in circulation
    i. Function in body immune response – defend against parasites, bacteria, viruses
    ii. Circulate through the body in the blood – work is usually carried out in tissues

3 subgroups

c. Immunocytes – responsible for specific immune responses against invaders
i. Lymphocytes – produced directly from Pluripotent stem cell.
1. T lymphocytes and B lymphocytes that produce specific immune responses involving antibodies directed against invaders
d. Phagocytes – develop from the same committed progenitor cell; can engulf and ingest foreign particles via phagocytosis
i. Monocytes – will leave circulation and develop into macrophages in the tissues
ii. Neutrophils – also a granulocyte; first cells to exit capillaries and enter tissues in response to infection
e. Granulocytes – contain cytoplasmic inclusions that give them a granular appearance
i. Eosinophils – produce toxic compounds directed against pathogens (especially parasites)
ii. Basophils (in tissues = mast cells) – secrete histamines (increases inflammation) and heparin (inhibits local clotting)
iii. Also neutrophils

  1. Platelets (formed from megakaryocytes).
    a. Cellular elements produced from fragmentation of large bone-marrow cells – parent megakaryocytes
    i. Grow so large due to repeated DNA replication without undergoing division (polyploid cells)
    ii. Outer edges of megakaryocytes extend through endothelium into lumen of blood sinuses in bone matrix – fragment into platelets
    b. Smaller than RBC – colourless and anucleate
    i. Still have organelles – mitochondria, SER, granules (cytokines and growth factors)
    c. Always present – lifespan is ~10 days
    d. Primary function is hemostasis – prevention of blood loss via coagulation in damaged blood vessels
    i. Also function in immunity – mediators of inflammatory response
34
Q

Hematocrit

  • average
  • determined by
  • high causes
  • low causes
A
  1. % of blood that is erythrocytes
    - On average ~42% (women) and 47% (men)
  2. Determined by Complete Blood Count (CBC).
    a. Blood is centrifuged – blood column separated into 3 layers:
    i. RBCs packed at the bottom of the tube – heavy
    ii. Middle layer of WBCs (also known as the buffy coat)
    iii. Upper layer of plasma – lightest
    b. Percentage of the blood column that is packed RBCs = hematocrit.
  3. High hematocrit - can indicate
    a. Dehydration
    b. Polycythemia vera – condition causes the body to produce too many blood cells (both RBCs and WBCs), in which case hematocrit may be elevated to 60—70%
    c. Blood becomes viscous and more resistant to flow
  4. Low hematocrit – anemias  low hemoglobin content of blood; decreases its ability to carry oxygen
    a. Occur due to
    i. Blood loss (hemorrhage)
    ii. Accelerated rate RBC loss
    iii. Decreased RBC production.
    b. Symptoms – tired and weak
    c. Examples:
    i. Hemolytic anemias – cells rupture at abnormally high rate; can be hereditary or acquired.
  5. Hereditary spherocytosis – defective cytoskeletal elements change cell shape to a sphere that ruptures easily in response to osmotic changes.
  6. Parasitic infections (acquired) such as malaria – parasite infects RBCs, proliferates and ruptures cells.
    ii. Sickle cell anemia – genetic disorder affecting amino sequence hemoglobin beta chain
  7. Hb crystalizes when it gives up o2 – pulls RBC into crescent moon shape
    a. Become tangled – causes blockages in blood flow to tissues; creates tissue damage and pain
  8. Can be treated with hydroxyurea – inhibits DNA synthesis; immature RBC produce fetal instead of adult Hb which interferes with crystallization
    iii. Aplastic Anemia – bone marrow has few stem cells, so all blood cell production is reduced (including RBCs).
    iv. Iron Deficiency Anemia – low iron levels due to dietary deficiencies, blood loss (e.g. menstruation), inability to absorb iron (e.g. Celiac’s disease which damages absorptive surface of intestine)
  9. less iron  less heme  less hemoglobin
  10. can have low RBC or low Hb – RBC are usually smaller and paler than normal
    v. Vitamin Deficiency Anemia -
  11. Dietary deficiency or trouble absorbing Folic acid, Vitamin C, or Vitamin B12 leads to abnormal RBC production (fewer cells, & larger cells).
35
Q

Hematopoiesis

A

production of formed elements from pluripotent hematopoitic cells in the bond marrow

  1. Pluripotent stem cells can develop into many types of cell types
    a. Become uncommitted stem cells  then progenitor cells  differentiate into RBC, WBC, and megakaryocytes
    b. Only 1 in 100,000 cells in bone marrow is an uncommitted cell – difficult to study and isolate
    i. Presents an therapeutic agent for cancer patients – can use blood from umbilical cord at birth
  2. Bone marrow – soft tissue that fills hollow centers of bone; contains blood cells in different stages of development and supporting tissue
    a. Red marrow = active hematopoiesis
    i. Hematopoiesis – synthesis of blood cells; begins early in embryonic development and continues throughout lifetime
  3. 3rd week fetal development – specialized cells in the yolk sac form clusters
    a. Some become endothelial lining of blood vessels & some become blood cells
    b. Relationship could explain why cytokines controlling hematopoiesis are released by vascular endothelium
  4. Continued development – blood cell production spreads to liver, spleen, bone marrow
  5. At birth – liver and spleen no longer produce blood cells
  6. Continues in all bone marrow until age 5 – continued aging of child into adult will see a decrease in the active regions of bone marrow in blood cell production
  7. Adults – pelvis, spine, ribs, cranium, proximal ends of long bones are active regions
    ii. Active bone marrow – red due to hemoglobin (o2 binding protein of RBC)
  8. 25% of cells are RBC
    a. Lifespan is about 4 months
  9. 75% are WBC
    a. Lifespan is much shorter – must be replaced more frequently
    i. ex. neutrophils – 6 hour half life; more than 100 million are produced every day
    b. Yellow marrow = inactive hematopoiesis
    i. Yellow due to high concentration of adipocytes
    ii. Inactive regions can resume cell production in times of need
36
Q

Cytokines

  • def
  • types
A

Peptides or proteins released from one cell that affects the growth or activity of another cell; regulates specialization of stem cells into specific blood cells
- Newly discovered cytokines are often called factors

Types

a. Interleukins (e.g. IL-3)
i. variety of functions including stimulation of uncommitted stem cells to form committed progenitor cells.
1. Important role in immune system
ii. Produced and released by WBCs to act on other WBCs
iii. Numbered once their AA sequence has been identified
b. Erythropoietin (EPO)
i. Stimulates and controls erythropoiesis (red blood cell production) – assisted by other cytokines
1. Usually called a hormone – still a cytokine because it’s made on demand instead of being stored in vesicles like other peptide hormones are
2. Homeostatic – increased EPO production  more RBC  more hemoglobin  can bind more o2
ii. produced and released by the kidneys in response to low oxygen levels (hypoxia)
1. hypoxia stimulates production of transcription factor hypoxia-inducible factor 1 – turns on EPO gene to increase EPO synthesis
2. People who are adapted to live at high altitude have a higher hematocrit as a result.
iii. Erythroblasts (nucleated)  Reticulocyte  Erythrocyte (anucleate)
1. Committed progenitor will differentiate into nucleated erythroblasts – maturation causes shrinking and loss of nucleus and other organelles
2. Leaves bone marrow as immature reticulocyte (anucleated) – enters circulation and matures into erythrocyte
3. Results in flattened, biconcave disk-shaped erythrocytes – lack nucleus and organelles.
iv. Took a very long time to identify AA sequence but was used clinically very quickly
1. Erythropoiesis stimulating agents – can be beneficial to cancer patients; risk of blood clotting
2. There is possible risk of hematopoietic drugs causing hemtological disease
c. Colony Stimulating Factors (CSFs)
i. stimulate leukopoiesis (white blood cell production) – induces cell division and cell maturation in stem cells
1. once a leukocyte matures – it loses its ability to undergo mitosis
ii. Secreted by endothelial cells, fibroblasts in bone marrow, and other leukocytes.
1. WBC are able to produce – allows leukocyte development to be tailored to bodies’ needs
iii. Responds to need. (e.g. during bacterial infection, CSFs stimulate production of neutrophils and monocytes.; viral infections cause increase in proportion of lymphocytes).
1. When WBC are required – absolute number of leukocytes and relative proportions of different types of leukocytes in circulation change
a. Clinically – differential white cell count assists in identification of type of infection (ex. bacterial vs viral)
i. Controlling leukopoiesis – can assist in developing treatments for diseases that lack or have excessive amounts of leukocytes
1. Leukemias – diseases with abnormal growth and development of leukocytes
2. Neutropenia – too few leukocytes; unable to fight bacterial and viral infections
d. Thrombopoietin (TPO) – glycoprotein (thrombocyte = platelet)
i. regulates growth and development of megakaryocytes (and therefore platelet production).
ii. Produced and secreted by the liver.
iii. Not everything about them is understood

37
Q

Cell differentiation

A

pluripotent hematopoietic stem cell

lymphatic stem cell -> lymphocyte

uncommitted stem cell -> committed progenitor 
1.  - eosinophils 
2.  - basophils 
3. 
neutrophil 
- monocyte
4. megakaryocyte -> platelets 
5. erthythroblast -> reticulocyte -> erythrocyte
38
Q

Hemostasis

4 stages

A

Preventing blood loss

  1. Vasoconstriction (vascular spasm)
    a. Damage to blood vessel wall activates local pain receptors – triggers an increase in sympathetic activity & vasoconstriction that reduces blood flow to the site of damage.
    b. Platelets stick to exposed collagen fibers (not normally accessible since they’re in the ECF) and release platelet factors – ions/molecules/cytokines
    i. Some reinforce vasoconstriction including:
  2. Serotonin (from secretory vesicles of platelets)
  3. Thromboxane A2 (from platelet membrane)
  4. Platelet Plug Formation
    a. Platelet adhesion – platelets stick to exposed collagen and release factors that attract other platelets to the site (positive feedback); fill in damaged area & form platelet plug.
    i. Integrins – membrane receptor proteins linked to cytoskeleton; allows binding & activates platelets and release platelet factors
    b. Platelet factors involved in aggregation:
    i. Platelet Activating Factor (PAF) – sets up positive feedback loop by activating more platelets
  5. Initiates pathway that convert platelet phospholipids to thromboxane A2
    ii. Serotonin (from secretory vesicles of platelets)
  6. Also causes vasoconstriction
    iii. Adenosine diphosphate (ADP) (from platelet mitochondria)
    iv. Thromboxane A2 (from platelet phospholipids)
  7. Also causes vasoconstriction
    c. Platelet plug formation cannot spread beyond the site of injury due to secretion of prostacyclin and nitric oxide (NO) from surrounding endothelial cells – blocks adhesion and aggregation
    i. Prevents thrombus – blood clots that adheres to undamaged blood vessel and blocks flow
    ii. Mutations affecting platelet function – can lead to clotting (heart attacks, strokes) or excessive bleeding
  8. Coagulation (Clot Formation) – blood forms gelatinous clot
    a. Cascade/Network of factor interactions activated through two pathways almost simultaneously – will merge into one
    i. Intrinsic Pathway (Contact Activation Pathway)
  9. Initiated by factors in blood exposed to collagen
    a. Collagen  activates tissue factor XII)
    ii. Extrinsic Pathway (Cell Injury/Tissue Factor Pathway)
  10. Initiated when damaged tissues expose tissue factor
    a. Tissue Factor III/tissue thromboplastin  activates factor VII
    b. Each pathway results in activation of Factor X – formation is the start of the common pathway
    i. Factor X:
  11. Combines with Ca2+, Factor V, and phospholipids – forms prothrombin activator.
    a. Prothrombin activator – converts prothrombin (inactive plasma protein) to thrombin (active)
  12. Positive feedback onto extrinsic pathway – actives more Factor VII and tissue factor III
    c. Thrombin – enzyme
    i. Acts on Fibrinogen (soluble clotting protein in plasma) – produce insoluble Fibrin polymers.
  13. Fibrin – forms a web of thread-like protein that covers the platelet plug and traps formed elements (RBCs).
    ii. Exerts positive feedback on intrinsic pathway - activates more Factor XI = plasma thromboplastin
    d. 2 dozen factors are involved – obtained from the diet, liver (plasma proteins), damaged tissue, and platelets
    i. Active Factor XIII (Fibrin Stabilizing Factor) – converts fibrin into a cross-linked polymer, and stabilizes the clot.
    ii. Vitamin K – required for synthesis of 4 factors (II, VII, IX, X)
    e. Clots – only temporary fix
  14. Fibrinolysis (Clot Dissolution) – after blood vessel wall has been repaired
    a. Plasmin – fibrin digesting enzyme; breaks down clot (fibrinolysis)
    i. Thrombin and tissue plasminogen activator (tPA) – convert plasminogen (inactive) in clot to plasmin (active)
    b. Phagocytes remove the clot in clumps.

SEE FLOW CHARTS

39
Q

2 mechanisms that prevent the spread of clots

errors in hemostasis

A

2 mechanisms limit the spread of clot
1. Inhibition of platelet adhesion
2. Inhibition of the coagulation cascade and fibrin production
a. Anticoagulants – produced by the body & block parts of coagulation cascade
 Body produces:
• Heparin – inhibit active Factors IX-XII
• Antithrombin III – inhibit active Factors IX-XII
• Protein C – inhibit active factors V and VIII

Errors in hemostasis

  1. Thrombus = stationary clot in an undamaged vessel (increases resistance to blood flow)
  2. Embolus = free floating clot
    a. can cause blockage of small vessels of the lungs (pulmonary embolism) or brain (cerebral embolism = stroke) or heart (coronary embolism – leads to myocardial infarction/heart attacks)
    b. can treat with fibrinolytic drugs, tissue plasminogen activator, antiplatelet agents, acetylsalicylic acid (aspirin)
  3. Hemophilia
    a. Clotting is abnormal or absent
    b. Majority of people with hemophilia are lacking clotting factor VIII (also known as Antihemophilic Factor)
    c. Recessive sex linked – usually affects only males
40
Q

Immunity

  • definition
  • immunogens
  • antigens
  • self vs non
  • early pathogen exposure
A
  1. Immunogens – substances that trigger the bodies immune response
    a. Antigens – immunogens that react with products of immune response
  2. Leukocytes – carry out internal immune response
    a. Dependant on cell to cell communication
    i. Chemical communication – substances released by damaged or dying cells; cytokines (protein signal molecules released by one cell that affect the group of another)
    ii. Contact dependant signaling – surface receptors on one cell recognize and bind ot surface receptors on another cell
  3. Main function of immune system – maintain homeostasis via
    a. Self cells
    i. Recognize and remove abnormal self cells – created when normal growth and development go wrong; cancerous, defective
    ii. Removing dead or damaged cells (ex. old RBC)
    b. Non self cells
    i. Prevent or limit infection due to viruses, bacteria, fungi, parasites (protozoans and worms), pathogens, allergens
  4. Not all pathogens can be destroyed – sometimes body can only localize infection and prevent spread (ex. tuberculosis, malaria, herpes)
  5. Early pathogen exposure – strengthens immunity
    a. Eradication of disease has seen an increase in autoimmune and allergic diseases (asthma, food allergies, IBS)
    b. Hygiene hypothesis – challenging the immune system strengthens it; too clean of an environment causes a weakened immune system (limited support)
    c. Suggested that it is not lack of exposure but lack of diversity in human microbiome
41
Q

Internal respose cells

A

Leukocytes – communicate using cytokines
o Cytokines – autocrine, paracrine, hormonal signals

Cell types 
o	Macrophages (monocytes)
o	Dendritic Cells
o	Microglia (in the central nervous system)
o	Neutrophils
o	Mast Cells (from basophils)
o	Eosinophils
o	Natural Killer Cells
o	Lymphocytes (T and B Lymphocytes)
42
Q

Immune tissues

A

Least anatomically identifiable; integrated into the tissues of other organs
- Positioned wherever pathogens are most likely to enter the body – ex. mucosal membranes of oral cavity
- 2 anatomical components
o Lymphoid tissue
o Cells responsible for immune response

Lymphoid tissues

  1. Primary lymphoid tissues – location of leukocyte production
    a. Thymus gland – site of production of T lymphocytes
    b. Bone marrow – produces all other leukocytes
    i. Pluripotent stem cells
    ii. Plasma cells???????**
  2. Secondary lymphoid tissues – location of leukocyte maturation, proliferation, interaction with pathogens
    a. Encapsulated tissues – have fibrous collagenous capsule walls; immune cells are positioned so they monitor ECF for foreigners
    i. Spleen – monitors blood; pathogens in blood will be exposed to active immune cells
  3. 3 areas
    a. Red pulp – closely associated with blood vessels/sinuses; contains many macrophages that help to filter blood and phagocytize old RBCs
    b. White Pulp – similar in structure to lymph nodes; composed mainly of lymphocytes
    c. Capsule – outer protective casing
    ii. Lymph Nodes – monitor interstitial fluids via lymphatic system; also monitor blood (like the spleen)
  4. Similar structure to spleen – has a capsule
  5. Closely associated with capillaries of CV system
    a. Excess fluid from net filtration is picked up – pathogens that enter are passed through encapsulated lymph nodes on their way to the heart
    b. Once in lymphatic circulation – clusters of immune cells in lymph nodes try to capture to prevent spread
    b. Unencapsulated tissues – diffuse lymphoid tissues; aggregation of immune cells in other organs and tissues in the body
    i. Mucosal Associated Lymphoid Tissue (MALT) – diffuse lymphoid tissue lining digestive, respiratory, reproductive, urinary tracts.
  6. Immune cells are positioned to intercept invading pathogens before they can enter general circulation
  7. Includes
    a. Tonsils
    b. GALT (gut associated lymphoid tissue) – lies just under epithelium of the esophagus and intestines
  8. Can be considered body’s largest immune organ
43
Q

Innate immunity

  • characteristics
  • components
A
  1. First line of defense
    a. Acts within minutes – lasts for hours
    b. Occurs independently of antibodies
    i. Some antibodies can help mediate the process if present
  2. Characteristics
    a. Immediate and rapid response
    b. Non specific response – acts on anything identified as non self
    c. No memory cells – must be retriggered each time
    i. Response is not remembered by immune system
    d. Present from birth
  3. Components
    a. First line of defense – physical, chemical, mechanical barriers
    i. Skin, mucous, tears, stomach acid
    b. Cellular barriers – circulating and stationary leukocytes programmed to respond to foreign materials
    i. Antigen presenting cells – dendrites and macrophages; required for both innate and adaptive responses
    ii. Ex. component of bacterial cell wall is recognized and ingested by phagocytes
  4. Phagocytes – antigen presenting cells; present pieces of digested cell on their cell surface to attract cells involved in adaptive immune response
44
Q

Barriers of innate immune system

A

Physical barriers

  1. Skin – tough protective outer layer
    a. Cells are keratinized
    b. Sweat from sweat glands – contains bactericidal chemicals (lysozyme)
    c. Sebum (oil) from sebaceous glands – blocks pores and reduces cracking in skin
  2. Nose hairs and eyelashes – filter larger airborne particles
  3. Mucous membrane – lines all body cavities/tracts that open to the outside of the body
    a. Respiratory, gastrointestinal, urinary, reproductive tracts
    b. Mucous produced by Goblet cells – traps pathogens and other particles

Mechanical barriers – flushing mechanisms (cilia that move and create flow)

  1. Mucociliary escalator
    a. Mucous membrane of respiratory tract – composed of ciliated pseudostratified epithelium
    i. Mucous produced by goblet cells traps microbes/debris
    b. Cilia in bronchi and trachea – beating (movement)pushes the mucus along with its trapped microbes/debris from the lungs towards the pharynx (throat).
  2. Flow of tears – produced by the lachrymal gland; flow over the surface of the eye diagonally, removing microbes and debris.
  3. Flow of urine – removes microbes and debris from the urinary tract.
  4. Coughing and Sneezing – blows out irritants (at speeds ≥ 160 km per hour)

Chemical barriers

  1. Chemical molecules that activate leukocytes
    a. Chemotaxis – attract leukocytes
    b. Opsonin’s – molecules that coat foreign particles; mark for consumption by phagocytes
    c. Pyrogens – cytokines that raise temp of body by altering hypothalamic set point
  2. pH – acidity creates inhospitable environment for microbes
    a. skin – pH = 4.5-6 (called the “acid mantle”)
    b. stomach – HCl; pH = 1-2
    c. mucous membrane
    i. ex. nasal cavity – pH = 5.5-6.5
  3. Enzymes – damage microbes (especially bacteria)
    a. Lysosomes – damage bacterial cell walls of unencapsulated bacteria
    i. Found in many body fluids – tears, sweat, saliva, intestinal and bronchial mucous, breast milk
    b. Proteases – antibacterial activity
    i. Ex. pepsin – digestive enzymes associated with gastrointestinal tract
  4. Antibodies
    a. IgA (immunoglobin A) antibodies – binds to pathogens; clumps together and marks for phagocytosis in case they cross into the internal environment
    i. Found in many body fluids – tears, sweat, saliva, intestinal and bronchial mucous, breast milk
  5. Acute phase proteins – plasma proteins produced in the liver; increase immediately following invasion
    a. Include – opsonins, C reactive proteins (CRP)
    b. Levels of acute phase proteins usually decline as immune response proceeds
    i. Chronic inflammatory disease – elevated levels persist (ex. rheumatoid arthritis)
    ii. Increased CRP – implicated in atherosclerosis coronary heart disease **
  6. Histamines – primarily found in granules of mast cells and basophils
    a. Actions – bring more leukocytes to injury to kill bacteria and remove debris by dilating blood vessels (increase flow) and opening pores in capillaries
    i. Capillaries – become leaky; plasma proteins are able to cross into ISF
    ii. Can lead to tissue edema (swelling) – pulls water with them due to osmotic flow
    b. Causes hot, red, swollen area
  7. Complement system – part of initial response to bacterial invasion
    a. Cascade of over 30 proteins (found in ECF) that result in phagocytosis or lysis of foreign cells
    i. Proteins – secreted in inactive form and activated via cascade (similar to coagulation)
  8. Act as chemotaxins – direct leukocytes to invading pathogens
    ii. C3 – most important protein in cascade
  9. Specifically C3b portion – functions in opsonization (flagging/marking of bad cells)
    b. 2 pathways
    i. Classical pathway – requires that adaptive immune response has occurred
  10. C1 proteins are activated by binding to antibodies (IgG, IgM) that are bound to pathogen/bacteria
  11. Produces C3 and C3b
    ii. Alternative pathway – completely innate response
  12. Carbohydrates on pathogen surface directly activate formation of C3 and C3b
    c. Function of both pathways
    i. C3 production – acts as opsonin that flags/marks pathogens for phagocytosis
  13. Phagocytes – have C3 receptors
  14. Opsonization – flagging/marking of bacteria for consumption by phagocytes
    a. Opsonins – chemical attractant; cause mast cell degranulation as well
    ii. C3b – helps to form membrane attack complexes (MAC)
  15. MAC – group of lipids soluble proteins that insert themselves into cell membrane of pathogens and virus infected cells to form pores
  16. C3b is converted to C5b – punctures holes in microbe cell membranes; allow Na+ and water to enter and cause lysis
    iii. C3a and C5a – by products of pathway; activate basophils and mast cells (inflammatory response)
    a.
  17. Interferons
    a. Function of interferons
    i. Play an important role in short term innate immune defense against viruses
    ii. Reinforces other immune activities
  18. Enhances macrophage phagocytic activity
  19. Stimulates antibody production
  20. Enhances action of NK cells
    b. Mechanisms
    i. Viral RNA enters cells (Covid-19, Influenza, west nile virus)
  21. Viruses use host cell for replication
    ii. Host cells produce interferons a and B (alpha and beta)
  22. Interferons act as paracrines – released from infected host cell and bind to cell membrane receptors on healthy neighbouring cells
  23. Triggers production of antiviral proteins (AVPs) in healthy cells
    iii. Virus replication is blocked in neighbouring cells with AVPs
  24. AVPs – are inactive if host cell is not infected
    c. Deficiency in interferon a and B is associated with more severe covid symptoms
45
Q

Cellular barriers of innate immune

A

Normal flora

  1. Skin microbiome – commensal (friendly) bacteria on skin surface
    a. Breaks down sebum oil – releases fatty acids that contribute to low pH of skin surface
    i. Sebum oil – oil and proteins mixture released from sebaceous/oil glands in skin
    b. Outcompete harmful microbes
  2. Gut microbiome – commensal bacterial in gastrointestinal tract
    a. Outcompetes harmful microbes
    b. Promotes production of antimicrobial peptides by intestinal epithelial cells
    i. Signal innate lymphoid cells in gut if pathogen is present – lymphoid cells release interleukin 22
    ii. IL-22 – cytokine; stimulates production and secretion of antimicrobial proteins by the epithelial cells
    c. Reinforce tight junctions between epithelial cells in the gut – help maintain the physical barrier

Immune cells of the body – includes all except T and B lymphocytes (adaptive only)
- Many cells have functions in adaptive – they connect the 2 processes
o Phagocytes – macrophages and dendritic cells that act as antigen presenting cells
 Not all are antigen presenting

46
Q

Inflammation

  • functions
  • 4 signs of inflammation
  • requires what

inflammatory response

A

Inflammation – hallmark of innate immune response
a. Functions
o Attract immune cells and chemical mediators to site
o Produces physical barrier to slow to spread of infections
o Promote tissue repair once the infection is under control
b. 4 signs of inflammation
o Redness (rubor)
o Heat (calor)
o Swelling (tumor)
o Pain (dolor)
c. Requires recognition of bacteria by – local macrophages, neutrophils, mast cells
o All have toll like receptors – able to detect bacterial cell wall components, lipopolysaccharide, flagella, etc.

Inflammatory response:

  1. Pathogen crosses physical barrier and enters body tissue
  2. Complement system is activated
    a. Activation of phagocytosis – C3b as opsonin, flags microbe for phagocytosis
    b. Activation of mast cells
    c. Production of membrane attack complex
    d. Some complement proteins are chemotaxins
  3. Phagocytosis of microbe by Resident Macrophages
    a. Resident macrophages may respond to toxins released by bacteria that have invaded via wound
    b. Macrophages release cytokines
    i. Interleukin 1 (IL-1) and Tumor necrosis factor-α (TNF- α)
  4. Cause blood vessel endothelial cells to express adhesion molecules – help leukocytes to emigrate from blood vessels
    a. Ex. selectins
  5. Stimulate liver to produce acute phase proteins – some are opsonins
  6. Both also act as endogenous pyrogens and cause fever – higher temp increases macrophage activity
    ii. Interleukin 8 (IL-8) – acts as a chemotaxin for neutrophils
  7. Neutrophil chemotactic factor – neutrophils have IL-8 receptor; helps attracts them to the infected area
  8. Mast cells – release Histamine & other proinflammatory cytokines (bradykinin, IL-1, etc.)
    a. Potent vasodilator – causes localized vasodilation & increases blood present
    i. Causes redness and (rubor and calor)
    ii. Bradykinin can cause vasodilation
    b. Increases capillary permeability – plasma proteins can leave blood and enter ISF
    i. Increases the colloid osmotic pressure of the ISF (πI.) – fluid moves into the ISF causing swelling & localized edema.
    c. Pain – caused by local distension within the swollen tissue
    i. Swelling can cause loss of function.
    ii. Locally produced cytokines (e.g. bradykinin) stimulate pain receptors.
    d. Release chemotaxins that recruit neutrophils??**
  9. Other leukocytes – emigrate from blood vessels into tissue (chemotaxis)
    a. Other leukocytes join
    i. Neutrophils come within 1 hour – attracted by chemotaxins
    ii. Blood monocytes follow – mature into macrophages over 8-12 hours.
    b. Steps of emigration:
    i. Margination – Neutrophils and Monocytes stick to endothelium of blood vessel
    ii. Rolling – selectins indicate to neutrophils and monocytes to slow down and “roll” along the interior of the vessel.
    iii. Diapedesis – neutrophils and monocytes leave the blood vessel using amoeba-like movement (squeeze themselves out through spaces between endothelial cells).
    iv. Migration – newly recruited phagocytes move through the tissue toward the injury site
    c. Phagocytosis by neutrophils & recruited macrophages (not only resident phagocytosis)
  10. Neutrophil elimination – phagocytosis of used neutrophils by macrophages
    a. After they’ve ingested 5-20 microbes – they no longer work
  11. Macrophages
    a. Recruited and resident macrophages – activated via Toll-like receptors, or opsonization by antibodies or complement proteins , continue eating
    b. Antigen presentation to Helper T cell occurs – link to Adaptive Immunity
  12. Local inflammatory response – acts to separate infected tissue from healthy tissue so that infection cannot spread.
    a. Only occurs at the area of the injury.
  13. Tissue heals
    a. Lymphatic system picks up extra tissues
47
Q

Leukocytes

  • where are they present
  • 6 basic types
  • 2 functional groups
A
  • Circulate in the blood – function extravascularly
    o Some may live outside of tissues for hours, days, months
  • 6 basic types
    o Basophils & mast cells – not often in blood; granulocytes
    o Eosinophils – granulocytes
    o Neutrophils – granulocytes
    o Monocytes – create macrophages
    o Dendritic cells – not often in blood
    o Lymphocytes & derived plasma cells
  • 2 functional groups
    o Phagocytes – neutrophils, macrophages, dendritic cells
    o Antigen presenting cells – macrophages & dendritic cells; B lymphocytes in adaptive
48
Q

Functions in innate and adaptive

Phagocytes

  • function
  • types
A

Not all are antigen presenting

Function of phagocytes
1. Identify microbes and other foreign particles by pathogen associated molecular patterns (PAMPs) with bind pattern recognition receptors (PRRs) on the phagocyte
a. Ex. PRR – toll like receptors
2. Extensions of phagocyte cell membrane wrap around pathogen (with PAMP binding PRR) – results in engulfing pathogen
a. Phagosome – ingested pathogen in cytoplasmic vesicle
b. Phagosome fuses with lysosomes – contains digestive and oxidizing agents
c. Phagolysosome – fusion of phagosome with lysosome
• Within – microbes are killed by
1. O2 dependant phagocytosis
- Uses oxidizing agents – ex. hydrogen peroxide, superoxide anion, nitric oxide) produced in the phagolysosome
• Harmful to most cells/pathogens
2. O2 independent phagocytosis
- Enzymatic breakdown of microbe by lysozyme (damages bacterial cell membrane), proteases, hydrolytic enzymes
- Lysis by antimicrobial peptides
• Ex. defensins – bind to cell membrane and form pores (similar to MACs); effective against bacteria, fungi, viruses
3. Can also ingest inorganic particles (asbestos and carbon) – cannot be digested/broken down enzymatically; they stay in cell

  1. Macrophages – formed from monocytes
    a. Monocytes – not very common in the blood (1-6% of WBC)
    i. In tissues – enlarge and differentiate into phagocytic macrophages
    b. Many names
    i. Histiocytes – skin
    ii. Kupffer cells – liver
    iii. Osteoclasts – bone
    iv. Microglia – brain
    v. Reticuloendothelial – spleen
    c. Phagocytes in tissues – are larger and more effective than neutrophils; ingest up to 100 bacteria during their lifespan
    i. Migratory macrophages – move around and patrol tissues; can be recruited to a particular area as part of the innate immune response
  2. Particularly in mucous membrane
    ii. Resident macrophages – single tissue; typically sessile (little movement or confined to one area)
  3. Ex. alveolar macrophages in the lungs
    d. Innate immunity
    i. Remove dead/dying cells, cellular debris, old RBCs, dead neutrophils
    ii. Ingest and digest pathogens
    e. Adaptive immunity
    i. Antigen presenting cells – present antigens (pieces of digested pathogens) to T cells
  4. Dendritic cells – long thin processes
    a. Phagocytes in tissues
    i. Found in skin (Langerhans cells) and other tissues
    ii. When activated – they migrate to lymphoid tissues (lymph nodes and spleen)
    b. Innate immunity
    i. Non specific pathogen recognition – ingest and digest pathogens
    c. Adaptive immunity
    i. Antigen presenting cells – present antigens to T cells in lymph nodes and spleen
  5. Microglia
    a. Phagocytes in CNS – function as resident macrophages
    i. BBB blocks entry of other leukocytes and antibodies from the blood
    b. Innate immunity
    i. Remove dead/dying cells, cellular debris
    ii. Ingest and digest pathogens
    c. Adaptive immunity
    i. In healthy/homeostatic CNS – none
  6. Neutrophils
    a. Phagocytes of blood – can leave circulation to enter tissues only in response to infection
    i. Most abundant WBC (50-70%)
    ii. Short lived – 1-2 days
  7. Only consume 5-20 bacteria
    b. Structure
    i. Segmented nucleus – polymorphonuclear cells; 3-5 lobes
  8. Can be used to identify
  9. Immature – has horse shaped nucleus
    c. Innate immunity
    i. First cell recruited to site of infection – attracted by chemotaxins produced via complement activation
    ii. Non-selectively removes invading microorganisms
    iii. Releases
  10. Pyrogens – fever causing cytokines
  11. Chemical mediators of inflammatory response
    d. Adaptive immunity – none
    i. Not antigen presenting
49
Q

Mast cells & basophils

Eosinophils

NK cells

A

Mast cells & Basophils

  1. Non phagocytic granulocyte
    a. Mast cells – present in tissues
    i. Precursor are basophils – present in circulation (rare)
    b. Concentrated in CT of skin, lungs, gastrointestinal tract – where they are most likely to encounter pathogens
  2. Covered with receptors for IgE – often bound to IgE
    a. Binding of IgE – triggers degranulation and release of chemical mediators of the innate immune response (indirectly assist in innate response)
  3. Innate immunity – signalling of cytokine release and inflammatory response; releases
    a. Histamine – mediates inflammation; sensitized in allergy
    b. Heparin – anticoagulant
    c. Chemotaxins – recruitment of other immune cells (ex. neutrophils)
  4. Adaptive immunity – release of histamine, heparin, chemotaxins in response to IgG and IgE **

Eosinophils

  1. Cytotoxic cells – normally in peripheral circulation
    a. Related to neutrophils
    b. 1-3% of WBC
    c. Short lived – 6-12 hours
    d. Concentrated in GI tract, lungs, urinary and genital epithelia, & CT of skin
    i. Reflect role in parasitic invaders
  2. Innate immunity
    a. Attack large, antibody coated parasites
    b. Exocytosis granzymes (hydrolytic enzymes) and Perforin on parasite cell surface – creates pore in cell membrane & kills parasite
    c. Allergic reaction – contributes to inflammation and tissue damage by releasing toxic enzymes and oxidative substances
  3. Adaptive immunity – some roles in coordinating response of T cells

Natural Killer cells

  1. Innate (non specific) lymphocytes – cytotoxic
    a. Thought to develop in bone marrow and other tissues
  2. Activated by interferons or macrophages
    a. Interferons – interfere with viral replication
    b. Macrophages – release cytokines that activate NKC to kill altered self cells (ex. viral or cancerous cells)
  3. MHC I (major histocompatibility complex I) receptors – inhibitory effects on NKC actions
    a. Healthy cells – have MHC I
    b. Pathogenic cells – lack MHC I; will attack
    i. Altered self cells/tumors – lack MHC I
    ii. Viral infection – will down regulate MHC I expression
  4. Innate immunity
    a. MHC I missing – activates NKC
    i. NK releases perforin in proximity to target cell – forms hydrophilic pore (similar to actions of MACs on bacterial cells)
    ii. Release granzyme B – cytotoxic enzyme that initiates apoptosis (cell death)
  5. Adaptive immunity – none
    a. T and B lymphocytes function
50
Q

Adaptive immune response

  • characteristics
  • 2 divisions
A
  1. Acquired immunity
  2. Second line of defense after innate
    a. Detection and identification of pathogen
    b. Communication with other immune cells – organized response
    c. Recruitment of assistance and coordination of response
    d. Destruction or suppression of pathogen
  3. Characteristics
    a. Slower – days to weeks
    b. Long lasting immunity – allows more rapid response to exposure next time
    i. Memory cells – remember (have receptors for) the epitopes and antigens of pathogens previously encountered
    c. Highly specific immune response
    i. Recognizes specific pathogen and initiates a unique response to it
  4. Pathogen – infectious agent
  5. Antigen – molecule body does not recognize as self
  6. Epitope – part of antigen the interacts with receptors on T cells, B cells, and antibodies
    ii. Depends on ability of T cells, B cells, and antibodies to bind and recognize the epitopes on antigens
  7. 2 divisions
    a. Cell mediated immunity – requires contact dependant signalling between immune cells (cytotoxic t-cells) and receptor on target
    b. Antibody mediated (humoral) immunity – production of antibodies by B lymphocytes and plasma cells
    i. Antibodies – proteins secreted by immune cells to carry out immune responses; bind to foreign substances to disable them & make them more visible to the cells of the immune system
51
Q

Adaptive immune cells

  • how many in body
  • clones
  • specificity

production of lymphocytes

types

A

Adaptive immunity cells – lymphocytes & derived plasma cells

  1. Plentiful – adult body contains a trillion (20-35% of WBC)
    a. Only 5% in circulation
  2. Each T and B cell can only bind to one antigen
    a. Clone – all the cells that bind that particular antigen; B cells with the same BCRs
    i. Millions of types
    ii. Body only keeps a few of each – if pathogen appear, the clone will reproduce in order to fight infection
    b. Specificity – in the proteins that become surface receptors or antibodies

Production of lymphocytes
- T lymphocytes – produced in thymus gland
o During development – one set of immature lymphocyte precursor cells migrate from bone marrow
- B cells – precursors remain in bone marrow

3 major types

  1. T lymphocytes
    a. Helper T cells (Th or CD4+ cells) – direct/mediate adaptive immunity
    i. Type 1 (Th-1 cells)
  2. Secrete
    a. INF-y (interferon-gamma) – activates macrophages
    b. IL-2 – activates cytotoxic T-cells
  3. Mediate cell mediated immunity
    ii. Type 2 (Th-2 cells)
  4. Secrete IL-4, IL-5, IL-6 – all help activate B cell growth, differentiation, and antibody production
  5. Mediate humoral immunity (antibody mediated) immunity
    a. Activate B cells
    b. Cytotoxic T cells (Tc or CD8+ cells)
    i. Once activated – attack and destroy virus infected cells that have specific antigen
    ii. Cause apoptosis of infected cells
  6. Release cytotoxic molecules – perforins and granzymes
  7. Activate Fas – death receptor protein on host cell
    c. Regulatory T cells – prevent excess immune response by supressing other lymphocytes
  8. B lymphocytes
    a. Responsible for humoral immunity – production of antibodies
    i. Most antibodies – in the blood (~20% of plasma proteins)
    ii. Antibodies are not toxic – cannot destroy antigens; only help immune system recognize
    iii. Most effective against extracellular pathogens – bacteria, parasites, antigenic macromolecules, viruses that have not yet invaded cells
    b. Naïve cells – exposed to antigen
    i. Create a primary immune response
    ii. Future exposures – secondary immune response
    c. Activated by Th-2 cells – clonal expansion occurs & cells develop into
    i. Plasma cells – effector cells
  9. Produce antibodies/immunoglobins (globular proteins) – from their B cell receptors (BCRs)
    ii. Memory B cells – long lived cells that enter circulation
  10. Allow for a more rapid response to a secondary infection – memory cells have B cell receptors that can bind to antigen & stimulate production of antibodies directly
52
Q

MHC molecules

TCRs

BCRs

Antibodies

A
  1. Major histocompatibility complex (MHC-1 & MHC-2) – membrane protein complexes that display antigens
    a. Contact dependant signalling – when MHC antigen interacts with T cell immune receptor
    b. MHC-1 – found on nearly all nucleated cells; displays antigen that has epitome that binds to TCR of cytotoxic T cells
    i. Bind to CD8 protein receptors on cytotoxic T cells
    ii. Important for immune responses involving infected host/body cells
    c. MHC-2 – found on antigen presenting cells (macrophages, dendritic cells, B cells); display antigens that has epitome that binds to TCR of helper T cells
    i. Binds CD4 protein receptor on helper T cells
  2. T cell receptors (TCRs) – protein receptors on T lymphocytes that recognize and bind to antigen presented by MHCs on surface of antigen presenting cell
    a. Unique for every antigen
    b. NOT antibodies
  3. B cell receptors (BCRs) – protein receptors on B cells that recognize and bind to specific antigen (ex. on MHC-II of antigen presenting cell)
    a. Essentially antibodies on the surface of B cells
    i. Proteins that comprise variable region of receptor have high mutation rate – millions of possibilities for receptor phenotype
    ii. Clone – B cells with same BCRs
    b. Immune response requires appropriate clone for antigen to be selected
    i. Clonal selection – binding of antigen to BCR
  4. Very specific – lock and key
    ii. Activation of B cells after recognition – via helper T cells
    iii. Clonal expansion – proliferation via mitosis
  5. Produces plasma cells and memory cells
  6. Antibodies – antigen recognition molecules; gamma globulin proteins
    a. Structure – 4 polypeptide chains in Y shape
    i. Fab – arms of Y
  7. Variable region – each arm can bind to one antigen (2 total)
  8. Each arm – one light chain (exterior), one heavy chain (continuous with Fc region)
    a. Chains are variable – gives them their specificity
    ii. Fc region – stem of Y; constant region that determines antibody class
  9. Binds to immune cells

b. 5 classes
i. IgM – early immune response
1. Strongly activate complement system of innate immunity
2. React to antigens on RBC (AB blood groupings)
3. More specific immune response against bacteria and some viral infections
ii. IgG - ~75% of all plasma antibodies
1. Released during secondary immune response – activates complement system of innate immunity
2. Passed from mother to fetus across placenta – imparts immunity newborn for first 6 months
3. More specific immune responses against bacteria and some viral infections
iii. IgE
1. Protects against parasites
2. Fc region binds to mast cells – antibody mediator of allergic responses
iv. IgA – found in secretion of mucous membranes
1. Digestive, respiratory, urinary, reproductive systems, tears, sweat, saliva, breast milk
2. Often associated with chemical barrier of innate immune response
v. IgD – found of the surface of B cells
1. Function unknown – may play a role in B cell activation

c. Function – bind to antigens to inactivate and remove them
i. Facilitates phagocytosis
1. Antigen clumping
2. Inactivation of bacterial toxins
3. Opsonization of bacteria
4. Via complement system of innate response (classical pathway)
ii. Cell lysis
1. Via complement activation (classical pathway) – formation of MACs
iii. B cell activation – production of more antibodies

53
Q

Primary & secondary responses of adaptive immunity

A

Primary response

  1. Naïve T and B lymphocytes – exposed to pathogen
  2. Clonal expansion occurs – mitosis of B cells and T cells that have the BCRs and TCRs for specifc antigen
  3. Differentiate into effector cells and memory cells
    a. Effector B cells – plasma cells
    i. Plasma cells – produce antibodies
    b. Effector T cells – helper T cells, cytotoxic T cells
  4. Memory B cells – remain in circulation; humoral immunity

Secondary response – immune memory

  1. Memory T and B lymphocytes in circulation are exposed to the same antigen that initiated their formation
    a. Clonal expansion – occurs more quickly; larger population of memory T and B cells than there was during primary response
    b. Increased number of
    i. Effector T and B cells
  2. More plasma cells = more antibodies compared to primary response
  3. More cytotoxic T cells = faster and more effective destruction of infected host cells
    ii. Memory T and B cells
54
Q

Cell mediated immunity

  • steps in secondary response (and primary)
A

Cell mediated immunity – effective against virus infected cells and cancerous cells
Steps in secondary response:
1. Pathogen invades tissue
2. Phagocytosis by resident macrophages and dendritic cells – antigen presentation on MHC-II
a. Type 1 helper T cells (CD4) – TCR binds to MHC-II; activates Th-1 cell
i. Th-1 cell secretes IL-2 (cytokine) – activates cytotoxic T lymphocytes (CD8)
b. Cytotoxic T cells – TCR binds to MHC-I complexes on infected host cells
i. Release perforin onto infected cell – creates pore
ii. Release granzymes into infected host cell – digests cell
c. Infected cell undergoes apoptosis

Primary response – would be similar
- Would require antigen presentation to Naïve T cells – then clonal expansion between 2. And 2a.
o Response would not be as quick or effective

55
Q

Humoral immunity

  • secondary response (and primary)
A

Humoral Immunity – antibody mediated immunity
Steps in secondary response
1. Pathogen invades tissue
a. Recognized by toll like receptors or opsonized by complement of antibodies
2. Phagocytosis of pathogen by resident macrophage or dendritic cell – antigen presentation on MHC-II
a. Type 2 helper T cells (CD4) – TCR binds to MHC-II; activates Th-2 cell
i. Th-2 cell secretes IL-4, IL-5, IL-6 (cytokines) – activates:
1. B cells to proliferate (clonal expansion)
2. Plasma cells to produce antibodies
3. Antibodies facilitate
a. Phagocytosis – act as opsonins
b. Cell lysis (apoptosis)
i. Via activation of classical complement pathway (MACs)
ii. Activating degranulation of NKCs or eosinophils
c. Facilitate production of more antibodies through actions on B cells

Primary response – would be similar
- Would require antigen presentation to Naïve B cell & clonal expansion between 2. And 2a.
o Response would not be as quick or effective

56
Q

2 types of humoral immunity

A
  1. Active immunity – body is exposed to the pathogen and produces its own antibodies via humoral response
    a. Natural – pathogen infects body through natural means
    i. Triggers a normal humoral response that leads to the production of antibodies
    ii. Person becomes ill and then recovers
    b. Artificial – vaccination
    i. Vaccines – mimic the pathogen
  2. Can be
    a. Attenuated/killed pathogen
    b. Purified macromolecules
    c. DNA
  3. Will cause slow primary response – harmless or mild symptoms
    ii. Fake pathogen triggers creates of antibodies and memory cells – long term immunity
    iii. Subsequent exposure to real pathogens produce fast and more effective secondary response
  4. Passive immunity – the body acquires antibodies that were made my another individual or organism (horses, sheep)
    a. Natural – the antibodies crossing form mother to fetus across placenta or breast milk
    b. Artificial – injections that contain antibodies (antiserums) as opposed to attenuated pathogen
    i. Antivenin for snake bites
    ii. Convalescent serum for severe Covid-19 or Ebola – produced by taking antibodies from a recovered person and injecting them into someone who is ill to boost their immune response
    iii. Post exposure to rabies, tetanus, Hep B – if person was exposed and not vaccinated
57
Q

Self tolerance

  • how to prevent autoimmunity
A

Self tolerance – lack immune response to cells of body; begins in embryonic development
- TCRs and BCRs – make randomly by DNA cutting and recombination processes
o There is a small chance of producing TCRs and BCRs that are self reactive
- Antigen recognition – leads to immune response
o If self antigen is recognized – causes autoimmunity (ex. type I diabetes where body cells destroy islet cells that produce insulin)

To prevent autoimmunity – during maturation, T cell clones and B cell clones have their TCR and BCR tested against self antigen & cells with TCR and BCR that recognize self antigen are destroyed or inactivated via
1. Clonal deletion
a. Occurs
- In thymus (T cells) and bone marrow (B cells) during fetal period up toa short time after birth
- Can also occur in the peripheral tissues and circulation
b. As T cells and B cells are produced – they are presented with self antigens
- No recognition – cells escape into circulation
- Recognition – clone undergoes apoptosis
2. Clonal inactivation (anergy) – occurs only in the tissues and circulation
o Causes self reacting cells to become non responsive

58
Q

Allergy

A

immediate hypersensitivity
- Overactivation in response to an antigen

First exposure – allergen activates pathways that create memory B cells and plasma B cells
a. Plasma B cells – produce IgE antibodies
• IgE – become bound to mast cells

Subsequent exposures – allergen interacts with IgE on mast cell

a. Cause release of histamine and proinflammatory cytokines
b. Creates a local inflammatory response in area of contact with allergen – red, swelling, heat, itch, etc

59
Q

External vs internal respiration

A

External respiration – exchange and transport of o2 and co2
o Pulmonary ventilation – between lungs and atmosphere; inspiration and expiration
o Exchange between alveoli and blood & between blood and tissue cells
o Transport from capillaries in the lungs to capillaries in the systemic tissues and back

Internal respiration = cellular respiration
o Use of o2 by mitochondria in cells to produce ATP
o Co2 is formed as a waste product

60
Q

Functions of respiration

A
  1. Homeostatic pH regulation of body – via the concentration of co2 by increasing or decreasing respiratory rate
    a. CO2 + h2o = h2co3 = H+ + hco3- (carbonic anhydrase reaction)
    i. Increased breathing = less co2 = less acidic
    ii. Decreased breathing = more co2 = more acidic
  2. Defending against microbes
    a. Mucociliary escalator – mucus traps pathogens and beating cilia move the mucus towards the pharynx
    b. Resident alveolar macrophages – phagocytize pathogens and debris in the alveoli
  3. Metabolic function – modifies arterial concentration of chemical messengers
    a. Removes and inactivates some messengers and enzymes
    i. Ex. 30% of NE in venous blood is removed in the lungs
    b. Produces and actives other messengers and enzymes
    i. Ex. angiotensin converting enzyme (ACE) – converts angiotensin I to angiotensin II (regulator of MAP and water balance)
  4. Vocalization – produced by moving air across the vocal cords in the larynx
  5. Sense of smell – requires inspiration to move molecules in nasal cavity to stimulate olfactory receptors (free nerve endings) in the roof of the nasal cavity
61
Q

Upper vs lower resp tract

A

Upper respiratory tract
Components
1. Nasal cavity – warms, humidifies, and filters air with nasal hairs
2. Mouth – alternative route for air entry from the atmosphere; not as effective at warming/humidifying/ filtering as nose
3. Pharynx – common passageway of food and air
4. Larynx – contains the vocal cords

Lower respiratory tracts 
Components 
-	Trachea 
-	Bronchi 
-	Bronchioles 
-	Alveoli (lungs)
62
Q

Thoracic muscles & lung anatomy

A
  1. Thoracic cavity – formed by vertebral column, rub cage, associated muscles
    a. Muscles involved in breathing
    i. Diaphragm
    ii. External intercostals
    iii. Internal intercostals
    iv. Sternocleidomastoid
    v. Scalenes
  2. Anatomy
    a. 2 lobes
    i. Right – 3 lobes
    ii. Left – 2 lobes
    b. Surrounded by pleura sac – double membrane
    i. Visceral pleura – inner membrane attached to the surface of the lung
    ii. Parietal pleura – outer membrane attached to the thoracic wall and diaphragm
    iii. Pleura cavity – space between; fluid holds membranes close together (due to adhesive forces of water molecules) and lubricates them during breathing
    c. ~23 divisions of branching – starting at trachea and ending at the alveoli
    i. Each division is shorter, narrower, thinner than previous
63
Q

Zones in resp tract

A
  1. Conducting zone/anatomical dead space – trachea to primary bronchi, secondary bronchi, bronchioles
    a. Walls – cartilage (less as you move down), smooth muscle, elastic tissue
    i. Mucous secreting epithelium – conditions the air by warming, humidifying, filtering the air
    b. Gases are transported in and out via bulk flow – pressure gradients (high to low)
    c. Total air volume = ~150mL
    i. Anatomical dead space – filled with air but no gas exchange can take place
  2. Ex. if you inspire 500mL, 150mL will be lost to dead space and only 350mL will reach the alveoli
  3. Respiratory zone – respiratory bronchioles to alveolar ducts, alveoli
    a. Walls – thin; no cartilage
    i. Bronchioles – very little smooth muscle (if any)
    ii. Alveoli – no smooth muscle
  4. Diameter of 1 alveoli = ~0.25m
  5. Elastin fibres between alveoli – tensile strength; stretch/recoil properties
    b. Very large surface area – lots of capillaries for gas exchange
    c. Gases move via bulk flow & diffusion
    i. Pores of Kohn – gaps between alveoli; allow gas exchange between adjacent alveoli
    d. Post inspiration air volume (at rest) = ~3000mL
    i. Increase when taking deep breaths (ex. during exercise)
  6. Respiratory membrane – 0.2-0.5 microns thick; site of gas exchange between lungs & blood
    a. Respiratory membrane is 3 layers
    i. Alveolar epithelium (wall) – 2 cell types
  7. Type 1 alveolar cells – squamous polyhedral cells; make up most of alveolus; allow diffusion of gases
    a. Resident macrophages – patrol surface of type 1
  8. Types 2 – spherical cells; secrete surfactant & reabsorb Na+ and h2o (prevent buildup of water in alveoli)
    ii. Basement membrane
    iii. Capillary wall – endothelium (flat simple squamous)
64
Q

Gas Laws

A

gases will move down pressure gradients (mmHg)
- contraction & relaxation changes pressures in cavity

Boyles Law  P1V1 = P2V2; relationship between volume and pressure

  1. Pressure is inversely related to volume
    a. Ex.
    i. P1 = 100mmHg
    ii. V1 = 1L
    iii. V2 = 0.5
    iv. P2 = (100)(1)/(0.5) = 200mmHg/L

Daltons law  total pressure of mixed gases = the sum of the partial pressure (P) that each gas exerts independently

  1. If humidity is high – this includes partial pressure of water vapour in air
  2. Atmospheric pressure at sea level = 760mmHg
    a. Changes in altitude and humidity cause changes from 760mmHg
    i. Increased altitude = decrease Po2 (lower atmospheric pressure)
    ii. Increased humidity = decrease Po2 (lower % of gas in atmosphere)
  3. Partial pressure of a gas = (atmospheric pressure)(% of gas in atmosphere)
    a. Ex. at sea level: Po2 = (760mmHg)(20.95%) = 159.22mmHg

Equilibrium – when liquid is exposed to air; gas molecules can enter the liquid and dissolve until equilibrium is reached

  1. At equilibrium  Pgas in air = Pgas in liquid
    a. Alveolar gas pressure affects pressure of gases dissolved in the blood plasma – gas will diffuse down their partial pressure gradients until equilibrium is reached
    i. O2 – alveoli to capillaries
  2. Pulmonary arterial blood Po2 = 40mmHg
  3. Pulmonary venous blood Po2 = 100mmHg
  4. Alveolar Po2 = 105mmHg
    ii. Co2 – capillaries to alveoli
  5. Pulmonary arterial blood Pco2 = 46mmHg
  6. Pulmonary venous blood Pco2 = 40mmHg
  7. Alveolar Pco2 = 40mmHg
65
Q

lung volumes and capacities

  • restrictive vs obstructive lung diseases
A

can be used to determine normal/abnormal function during a pulmonary function test with spirometer

  1. Tidal volume (TV) – volume air that moves into or out of lungs in one breath
    a. ~500mL at rest
    i. Inspiration = 500mL
    ii. Expiration = 500mL
  2. Inspiratory reserve volume (IRV) – max volume of air that can be inspired following a normal breath in (beyond tidal volume)
  3. Expiratory reserve volume (ERV) – max air volume that can be expired following a normal expiration
  4. Residual volume (RV) – volume of air remaining in lungs following max expiration; helps to keep lungs inflated
  5. Vital capacity (VC) – max volume of air that can be exchanged per breath
    a. VC = TV + IRV + ERV
  6. Total lung capacity (TLC) – max amount of air that the lungs can hold
    a. TLC = TV + IRV + ERV + RV
  7. Functional residual capacity (FRC) – amount of air held in the lungs after tidal expiration
    a. FRC = ERV + RV
  8. Forced expiratory volume in 1 second (FEV1) – volume of air expired in one second during a forced maximal expiration after taking max inspiration
    a. Can be compared to vital capacity to determine lung function  FEV1/VC ratio
    i. Normal FEV1/VC = 0.80 (80%)
    ii. Obstructive lung disease – impaired expiration (shortness of breath)
  9. Low FEV1/VC ratio (small FEV1)
  10. Asthma, bronchitis (inflammation of bronchi), emphysema (walls of alveoli are damaged creating fewer larger alveoli), chronic obstructive pulmonary disease (COPD)
    iii. Restrictive lung disease – impaired inspiration; lungs can’t fully expand
  11. Normal ratio but both FEV1 and VC values are low
  12. Scoliosis (lateral curve of spine in thoracic region), pneumothorax (lung collapse), pulmonary fibrosis (thickening and scarring of lung), obesity
66
Q

Pressures in resp

A
  1. Atmospheric pressure (Patm) = 760mmHg (at sea level)
    a. All other pressures are calculated relative to this
  2. Intra-alveolar pressure (Palv) = pressure within alveolar
    a. +1 to -1mmHg relative to Patm
    b. Between breathes  Palv = Patm
    c. Changes to Palv – contraction/relaxation of respiratory muscles
  3. Intra-pleura pressure (Pip) = fluid pressure in pleura cavity; 756-753mmHg
    a. -4 to -7 mmHg relative to Patm – always negative during normal breathing and always less than Pip
    i. If Pip >/= Patm  pneumothorax (lung collapse)
  4. Ex. stab wound – would cause puncture thoracic wall and Pip = Patm
    ii. Becomes more negative during inspiration **
    b. Lungs and chest wall are elastic
    i. Opposing forces creates a negative pressure space so that Pip slightly decreases
  5. Thoracic wall – recoils outward
  6. Lungs – recoil inward
    ii. Cohesive forces of pleural cavity – holds lungs & wall together
  7. Transpulmonary (transmural) pressure (Tp) = pressure gradient between alveoli and intrapleural cavity; recoil pressure of lungs
    a. Tp = Palv – Pip
  8. Pressure gradient from Palv and Patm – drives ventilation
    a. F = P/R
    i. F = volume of inspiration/expiration
    ii. P = Patm – Palv
  9. Greater the difference = more air will flow
  10. Changes to Palv are made by contraction/relaxation of respiratory muscles
    iii. R = resistance of airway
  11. Determined by diameter of bronchi/bronchioles
    a. SNS – bronchodilation (smooth muscle relaxes; beta receptors)
    b. PSNS – bronchoconstriction
67
Q

Inspiration vs expiration

  • tidal breathing
  • deep breathing
A

Inspiration – tidal breathing (quiet)

  1. Palv = Patm (between breaths)
  2. Contraction of diaphragm (flatten) and external intercostal muscles (up and out) – chest wall expands
    a. Pip decreases – volume increases via expansion of thoracic cavity
    b. Tp increases (difference between Palv and Pip) – causes lungs (alveoli) to push out & lung volume to increase
    i. Increase in lung volume = decreases Palv
    c. Palv < Patm – causes air to move into alveoli
  3. Air flow continues until Palv = Patm

Deep inspiration – additional muscles are recruited to further increase expansion of thoracic cavity
- Sternocleidomastoid & scalenes – pull ribcage superiorly

Expiration – tidal breathing (quiet)

  • Passive during quiet breathing – no contraction of muscles
    1. Palv = Patm (between breaths)
    2. Relaxation of diaphragm and external intercostals – compress thoracic cavity
    a. Pip increases – compression of intrapleural sac
    b. Tp decreases (Palv – Pip) – causes lungs (alveoli) to recoil
    i. Decrease in lung volume = increase Palv
    c. Palv > Patm – causes air to move out
    3. Airflow continues until Palv = Patm (then inspiration occurs)

Deep expiration – active; utilizes abdominal and internal intercostal muscles

68
Q

Lung compliance

  • high vs low
  • factors in compliance
A

Ability of lung to stretch and expand/distend
Measured by the change in lung volume as a result in the change in transpulmonary pressure
CL = change in lung volume / change in Tp
CL = change V/change P

Compliance
a. High = lungs stretch easily (easy inhalation)
o Large changes in lung volume due to small changes in Tp
o Obstructive lung diseases – difficulty expiring
- High compliance; low recoil (not able to “snap back”)
b. Low = stretches less easily; greater pressure is required to inflate (difficult inhalation)
o Small change in volume due to large changes in Tp
o Restrictive lung disease – difficulty inspiring
- Low compliance; high recoil (able to “snap back”)

Factors in compliance

  1. Stretchability and elasticity of the lung tissue
    a. Lung tissue – surrounded by connective tissue that contains elastin and collagen fibres
    i. Elastin – allows stretch and recoil
    ii. Collagen – not elastic; provides strength
    b. Loss or buildup of tissue changes compliance
    i. Loss – increases compliance; decreases recoil
  2. Age
    a. Loss of elastin and collagen – decreases recoil & increase compliance
    b. Impaired expiration
  3. Obstructive lungs disease – impaired expiration
    ii. Buildup (especially collagen) – decreases compliance
  4. Pulmonary fibrosis – stiffening of lungs due to chronic inhalation of fine particulate matter deep into lungs (asbestos, cigarette smoke)
    a. Triggers inflammatory response – leads to build up of collagen (scar tissue)
    i. Decreases compliance and impairs inspiration
    ii. Scar tissue also thickens membranes between alveoli – slows diffusion of gases
    b. Restrictive lung disease – impairs inspiration
  5. Alveolar surface tension – attractive forces (hyd bonds) between water molecules on surface of alveoli resist alveolar expansion and decreases compliance
    a. Stretching type II alveolar cells – causes secretion of surfactant
    i. Surfactant – mix of phospholipids and proteins; disrupts the hydrogen bonds between water and decreases forces which restrict alveolar expansion
  6. Increase compliance – prevents alveolar collapse
    b. Fetal development
    i. Synthesis begins ~24th week of fetal development – reaches adequate levels by 34th week
    ii. Newborn respiratory distress syndrome (NRDS) – deficiency in newborns that causes low compliance
  7. Treatment – spraying artificial surfactant into lungs; artificial ventilation
69
Q

Airway resistance

  • equation
  • factors that influence resistance
A

Airway resistance – determined primarily by diameter of bronchi

  • F = P/R
    1. Increased R = reduced airflow and ventilation
    a. Bronchodilation
    2. Decreased R = increased airflow and ventilation
    b. Bronchoconstriction

Resistance is influenced by

  1. Breathing mechanisms
    a. Airways (bronchi and bronchioles) are connected to alveolar walls via connective tissue
    i. Radial traction – airways are pulled in the direction of alveoli
  2. Inspiration – expansion of thoracic cavity and alveoli  increased radial traction pulls airways open & increases diameter
    a. Decreased resistance = increased airflow
    b.
  3. Expiration – compression of thoracic cavity and alveoli  less radial traction & smaller diameter
    a. Increased resistance = decreased airflow
  4. Smooth muscle tone
    a. Decreased = bronchodilation
    b. Increased = bronchoconstriction
    c. Controlled by
    i. Nervous system
  5. PSNS – increases muscles tone & causes constriction
  6. SNS – very little innervation; beta-2 receptors via epinephrine causes relaxation of smooth muscle & dilation
    ii. Paracrine agents
  7. Histamine – mast cells; both effects will decrease diameter and increase resistance to flow
    a. Contraction of smooth muscle
    b. Stimulates mucous secretion
    iii. Co2
  8. Increased co2 – dilation
  9. Decreased co2 – constriction
  10. Pathogenic states – obstructive respiratory diseases
    a. Asthma – episodes of inflammation and strong bronchoconstriction
    i. Due to hyperresponsiveness of smooth muscle to irritants – dust, cold, emotions
    ii. Chronically increases mast cells – increased histamine (constriction and mucous secretion)
    b. Chronic obstructive pulmonary disease (COPD)
    i. Emphysema – destruction and collapse of alveoli and smaller airways
  11. Loss of elastic fibres and elastic recoil – increases compliance but impairs expiration
  12. Trapped air in lungs – high residual air volume
    ii. Chronic bronchitis – often co-occurs with emphysema; inflammation of airways and accumulation of mucous increases resistance
  13. Mast cells – secreting proinflammatory cytokines
70
Q

Alveolar ventilation vs pulmonary ventilation

A

Alveolar ventilation < pulmonary ventilation – not all air that enters respiratory tract during tidal expiration will go to alveoli due to anatomical dead space
o End of inspiration – fresh atmospheric air fills dead space (150mL); lung volume is at max intake for a tidal breath
a. During expiration – 150mL low o2 dead space air + 350mL high o2 alveolar air exits
- Dead space – filled with 150mL of low o2 air
b. During inspiration – 150mL low o2 dead space air + 350mL of high o2 air fills alveolus
- Dead space – filled with 150mL high o2 air

Total pulmonary ventilation per minute (minute ventilation) = (tidal volume)(respiratory rate)
= (500mL/breath)(12 breaths/min)
= 6000mL/min

Total alveolar ventilation = (tidal volume – dead space volume)(respiratory rate)
= (500 mL/breath – 150mL/breath)(12 breaths/min)
= (350mL/breath)(12 breaths/min)
= 4200 mL/min

Changing alveolar ventilation:
a. Increasing alveolar ventilation – increasing breath rate and depth (hyperventilation)
o Increases alveolar Po2 and decreases Pco2 withing physiological limits
o Because dead space volume does not change – depth of breath is more important than respiratory rate
b. Decreasing alveolar ventilation – decreasing breathing rate and depth (hypoventilation)
o Decreases alveolar Po2 and increases Pco2 within physiological limits

71
Q

Ventilation patterns

A
  1. Eupnea – breathing is normal quiet (tidal) breathing
    a. 12-20 breaths/min
  2. Bradypnea – decreased respiratory rate
    a. <12 breaths/min
  3. Tachypnea – increased respiratory rate and decreased depth (panting)
    a. >20 breaths/min
  4. Hypoventilation – decreased alveolar ventilation due to decreased resp rate and depth
    a. <12 breaths/min
  5. Hyperventilation – increased alveolar ventilation due to increased resp rate and depth
    a. >20 breaths/min
  6. Dyspnea – shortness of breath and difficulty breathing
    a. Severe symptom of Covid, pneumonia, others
  7. Apnea – period of cessation of breathing; may occur in association with some breath disorders (ex. sleep apnea)
72
Q

Ventilation perfusion coupling

  • local controls
  • matching perfusion to ventilation
  • pathologies
A

Ventilation perfusion coupling – matching the rate of airflow (ventilation) into alveoli with the rate of blood flow (perfusion) past the alveoli
- Very important – blood from poorly ventilated alveoli will otherwise mix with blood from well ventilated alveoli and cause a decrease in Po2 in systemic arterial blood

Local control of arterioles and bronchioles by o2 and co2
1. Matching requires local regulation of smooth muscle tone in bronchioles and pulmonary arterioles in response to changes in Po2, Pco2 in the air, blood, surrounding ISF
2. Response will be opposite in pulmonary vs systemic arteries
a. In tissues
• High co2/low o2 – needs more o2
o Dilating – decreases resistance and increases flow (brings more o2 and clears out co2)
b. In alveoli
• High co2/low o2 – that section will not oxygenate blood well
o Constriction – increase resistance and slows flow to direct to better ventilated arterioles

Pco2

  1. Increases
    a. Bronchioles – dilate
    b. Pulmonary arteries – constrict (weak response)
    c. Systemic arteries – dilate
  2. Decreases
    a. Bronchioles – constrict
    b. Pulmonary arteries – dilate (weak response)
    c. Systemic arteries – constrict

Po2

  1. Increases
    a. Bronchioles – constrict (weak response)
    b. Pulmonary arteries – dilate (weak response)
    c. Systemic arteries – constrict
  2. Decreases
    a. Bronchioles – dilate (weak response)
    b. Pulmonary arteries – constrict
    c. Systemic arteries – dilate

Matching perfusion to ventilation
1. Decreased ventilation to area of lung
o Lower Po2, higher Pco2 in pulmonary blood  vasoconstriction in pulm art  decreased perfusion (blood flow)  perfusion matched to ventilation  diversion away to better ventilated areas
2. Decreased perfusion to area of lung
o Lower Pco2, higher Po2 in alveoli  bronchoconstriction  decreased ventilation  ventilation matched to perfusion  diversion of airflow away from area of poor perfusion to areas with better perfusion

Pathologies 
1.	Decreasing ventilation 
o	Pneumonia 
o	Asthma 
o	COPD – chronic obstructive pulmonary disorder 
o	Kristi** - would restrictive diseases not also decrease ventilation 
2.	Decreased perfusion 
o	Pulmonary embolism